{"questions":[{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10554797","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24417973","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16159874","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15075082","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15102679","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11563775","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1718487","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16239073","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17446074","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18781615"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18781615","offsetInEndSection":90,"text":"[A new database for ribosomal protein genes which are mutated in Diamond-Blackfan Anemia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1718487","offsetInEndSection":94,"text":"[Diamond-blackfan anemia: in vitro response of erythroid progenitors to the ligand for c-kit.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16239073","offsetInEndSection":67,"text":"[Diamond Blackfan anemia: A paradigm for a ribosome-based disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16159874","offsetInEndSection":113,"text":"[Specific Role for Yeast Homologs of the Diamond Blackfan Anemia-associated Rps19 Protein in Ribosome Synthesis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15102679","offsetInEndSection":142,"text":"[Defective ribosomal protein gene expression alters transcription, translation, apoptosis, and oncogenic pathways in Diamond-Blackfan anemia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17446074","offsetInEndSection":123,"text":"[Gene therapy cures the anemia and lethal bone marrow failure in a mouse model of RPS19-deficient Diamond-Blackfan anemia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11563775","offsetInEndSection":119,"text":"[The Diamond Blackfan Anemia Registry: tool for investigating the epidemiology and biology of Diamond-Blackfan anemia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15075082","offsetInEndSection":164,"text":"[High frequency of ribosomal protein gene deletions in Italian Diamond-Blackfan anemia patients detected by multiplex ligation-dependent probe amplification assay.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10554797","offsetInEndSection":61,"text":"[Telomere length in inherited bone marrow failure syndromes.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24417973","offsetInEndSection":91,"text":"[Ribosomal protein deficiency causes Tp53-independent erythropoiesis failure in zebrafish.]","beginSection":"title"}],"id":"550312b4e9bde6963400001c","body":"Which genes are known to be involved in Diamond-Blackfan anemia","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11286224","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9368331","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11543999","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7690865","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19577707","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12555210","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12483111","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15561677","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12468929","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21052952"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11543999","offsetInEndSection":81,"text":"[Mutations in the neutrophil elastase gene in cyclic and congenital neutropenia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12468929","offsetInEndSection":78,"text":"[Mutant elastase in pathogenesis of cyclic and severe congenital neutropenia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11286224","offsetInEndSection":90,"text":"[Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15561677","offsetInEndSection":38,"text":"[Congenital and acquired neutropenia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21052952","offsetInEndSection":33,"text":"[Cyclic and chronic neutropenia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7690865","offsetInEndSection":132,"text":"[[Long-term treatment with recombinant human granulocyte colony stimulating factor in patients with severe congenital neutropenia].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19577707","offsetInEndSection":84,"text":"[Fever of unknown origin (FUO) due to cyclic neutropenia with relative bradycardia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12555210","offsetInEndSection":123,"text":"[Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9368331","offsetInEndSection":128,"text":"[Frequency of point mutations in the gene for the G-CSF receptor in patients with chronic neutropenia undergoing G-CSF therapy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12483111","offsetInEndSection":116,"text":"[Role of neutrophil elastase in bone marrow failure syndromes: molecular genetic revival of the chalone hypothesis.]","beginSection":"title"}],"id":"5503133ae9bde6963400001d","body":"Which gene is most commonly associated with severe congenital and cyclic neutropenia","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1689595","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12731605","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12555210","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8624368","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18513342","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8152256","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12483111","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2471075","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10779444","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11286224"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11286224","offsetInEndSection":90,"text":"[Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12555210","offsetInEndSection":123,"text":"[Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8624368","offsetInEndSection":62,"text":"[Pathophysiology and treatment of severe chronic neutropenia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1689595","offsetInEndSection":164,"text":"[Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10779444","offsetInEndSection":160,"text":"[Differential expression and regulation of GTPases (RhoA and Rac2) and GDIs (LyGDI and RhoGDI) in neutrophils from patients with severe congenital neutropenia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12731605","offsetInEndSection":163,"text":"[The relationship between periodontal status and peripheral levels of neutrophils in two consanguineous siblings with severe congenital neutropenia: case reports.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2471075","offsetInEndSection":128,"text":"[Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18513342","offsetInEndSection":76,"text":"[Congenital neutropenia: diagnosis, molecular bases and patient management.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8152256","offsetInEndSection":155,"text":"[Contributions to neutropenia from PFAAP5 (N4BP2L2), a novel protein mediating transcriptional repressor cooperation between Gfi1 and neutrophil elastase.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12483111","offsetInEndSection":116,"text":"[Role of neutrophil elastase in bone marrow failure syndromes: molecular genetic revival of the chalone hypothesis.]","beginSection":"title"}],"id":"550313aae9bde6963400001f","body":"Which treatment leads to an increase in neutrophil counts in severe congenital neutropenia","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9326253","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9368331","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12555210","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9347577","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7690865","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18513342","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11957196","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1689595","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9209840","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17881643"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17881643","offsetInEndSection":184,"text":"[G-CSF treatment of severe congenital neutropenia reverses neutropenia but does not correct the underlying functional deficiency of the neutrophil in defending against microorganisms.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9368331","offsetInEndSection":128,"text":"[Frequency of point mutations in the gene for the G-CSF receptor in patients with chronic neutropenia undergoing G-CSF therapy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12555210","offsetInEndSection":123,"text":"[Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7690865","offsetInEndSection":132,"text":"[[Long-term treatment with recombinant human granulocyte colony stimulating factor in patients with severe congenital neutropenia].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9326253","offsetInEndSection":172,"text":"[Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1689595","offsetInEndSection":164,"text":"[Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11957196","offsetInEndSection":89,"text":"[Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9209840","offsetInEndSection":109,"text":"[Safety of long-term administration of granulocyte colony-stimulating factor for severe chronic neutropenia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9347577","offsetInEndSection":58,"text":"[Severe chronic neutropenia: pathophysiology and therapy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18513342","offsetInEndSection":76,"text":"[Congenital neutropenia: diagnosis, molecular bases and patient management.]","beginSection":"title"}],"id":"55031406e9bde69634000021","body":"What is the risk in G-CSF treatment for severe congenital neutropenia","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17693984","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23652668","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27742787","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12370767","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26835221","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21862995","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27326297","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10521349","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15947100","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27618325"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17693984","offsetInEndSection":34,"text":"[Thyroid cancer gender disparity.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21862995","offsetInEndSection":75,"text":"[Multikinase inhibitors: a new option for the treatment of thyroid cancer.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15947100","offsetInEndSection":34,"text":"[BRAF mutation in thyroid cancer.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27618325","offsetInEndSection":106,"text":"[Current Concepts in the Molecular Genetics and Management of Thyroid Cancer: An Update for Radiologists.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27742787","offsetInEndSection":72,"text":"[Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26835221","offsetInEndSection":63,"text":"[Alcohol and breast cancer tumor subtypes in a Spanish Cohort.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12370767","offsetInEndSection":130,"text":"[Homozygous proline at codon 72 of p53 as a potential risk factor favoring the development of undifferentiated thyroid carcinoma.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27326297","offsetInEndSection":105,"text":"[Follicular thyroid carcinoma presenting as acute cord compression due to thoracic vertebral metastasis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23652668","offsetInEndSection":38,"text":"[Multiple endocrine neoplasia type 2.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10521349","offsetInEndSection":80,"text":"[Semi-supervised methods to predict patient survival from gene expression data.]","beginSection":"title"}],"id":"5503145ee9bde69634000022","body":"How many different subtypes of thyroid cancer exist","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19708762","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23161287","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10940685","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26177323","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27492634","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21490438","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27899191","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25525544","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24570896","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15153437"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19708762","offsetInEndSection":57,"text":"[Neuroendocrine tumors and tumor syndromes in childhood.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10940685","offsetInEndSection":41,"text":"[Tumor markers in neuroendocrine tumors.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23161287","offsetInEndSection":70,"text":"[Systemic treatment of neuroendocrine tumors with hepatic metastases.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21490438","offsetInEndSection":56,"text":"[Endocrine tumors as part of inherited tumor syndromes.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27492634","offsetInEndSection":100,"text":"[Genetic associations with neuroendocrine tumor risk: results from a genome-wide association study.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26177323","offsetInEndSection":71,"text":"[An Update of Neuroendocrine Tumors of the Female Reproductive System.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25525544","offsetInEndSection":94,"text":"[WHO Grade 2 Neuroendocrine Tumor in a 15-Year-Old Male: A Case Report and Literature Review.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24570896","offsetInEndSection":152,"text":"[Neuroendocrine tumors show altered expression of chondroitin sulfate, glypican 1, glypican 5, and syndecan 2 depending on their differentiation grade.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15153437","offsetInEndSection":96,"text":"[Analysis of molecular pathways in neuroendocrine cancers of the gastroenteropancreatic system.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27899191","offsetInEndSection":93,"text":"[Genetic predisposition to endocrine tumors: Diagnosis, surveillance and challenges in care.]","beginSection":"title"}],"id":"55031628e9bde69634000024","body":"Which neuroendocrine tumors are associated with specific tumor syndromes","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9354427","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11248121","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12203792","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20966648","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20878367","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9823298","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12686550","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12490073","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11165748","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10741010"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20966648","offsetInEndSection":72,"text":"[Thyroid cancer of follicular cell origin in inherited tumor syndromes.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10741010","offsetInEndSection":62,"text":"[Mutation analysis of PTEN\/MMAC 1 in sporadic thyroid tumors.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12203792","offsetInEndSection":75,"text":"[Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11248121","offsetInEndSection":84,"text":"[PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9354427","offsetInEndSection":95,"text":"[Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9823298","offsetInEndSection":135,"text":"[Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12490073","offsetInEndSection":130,"text":"[Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11165748","offsetInEndSection":17,"text":"[Thyroid cancer.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20878367","offsetInEndSection":84,"text":"[Familial follicular cell tumors: classification and morphological characteristics.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12686550","offsetInEndSection":188,"text":"[Paired box gene 8-peroxisome proliferator-activated receptor-gamma fusion protein and loss of phosphatase and tensin homolog synergistically cause thyroid hyperplasia in transgenic mice.]","beginSection":"title"}],"id":"55031650e9bde69634000026","body":"Is PTEN involved in follicular thyroid carcinoma","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20087681","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9886394","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11321234","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1284333","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11224508","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10903798","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19514601","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8403556","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9459638","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18187547"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10903798","offsetInEndSection":139,"text":"[Thyrocyte interleukin-18 expression is up-regulated by interferon-γ and may contribute to thyroid destruction in Hashimoto's thyroiditis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11321234","offsetInEndSection":38,"text":"[Fas-FasL in Hashimoto's thyroiditis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19514601","offsetInEndSection":53,"text":"[[Role of apoptosis in pathogenesis of thyroiditis].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20087681","offsetInEndSection":62,"text":"[Autoimmune thyroiditis research at Johns Hopkins University.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9459638","offsetInEndSection":207,"text":"[Elevation of protein kinase C in thyrocytes isolated from a Lewis rat model of autoimmune thyroiditis prevents assembly of immunodetectable connexin43 gap junctions and reduces intercellular communication.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9886394","offsetInEndSection":124,"text":"[Fas\/Fas ligand-driven T cell apoptosis as a consequence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8403556","offsetInEndSection":126,"text":"[An excess of dietary iodine accelerates the development of a thyroid-associated lymphoid tissue in autoimmune prone BB rats.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1284333","offsetInEndSection":100,"text":"[Interactions between the immune system and the thyroid. Regulatory networks in health and disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11224508","offsetInEndSection":117,"text":"[Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18187547","offsetInEndSection":196,"text":"[Differential interactions between Th1\/Th2, Th1\/Th3, and Th2\/Th3 cytokines in the regulation of thyroperoxidase and dual oxidase expression, and of thyroglobulin secretion in thyrocytes in vitro.]","beginSection":"title"}],"id":"5503167be9bde69634000028","body":"How thyrocyte destruction is induced in autoimmune thyroiditis","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15719322","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16391555","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8447318","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16731003","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17034023","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20707220","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15067307","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15790351","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16320352","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18576360"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17034023","offsetInEndSection":60,"text":"[PTPN22 620W allele is not associated with aplastic anemia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16320352","offsetInEndSection":71,"text":"[The PTPN22 620W allele is a risk factor for Wegener's granulomatosis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15067307","offsetInEndSection":168,"text":"[Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16391555","offsetInEndSection":122,"text":"[Evaluating the role of the 620W allele of protein tyrosine phosphatase PTPN22 in Crohn's disease and multiple sclerosis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15719322","offsetInEndSection":158,"text":"[Lack of association between the protein tyrosine phosphatase non-receptor 22 (PTPN22)*620W allele and systemic sclerosis in the French Caucasian population.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18576360","offsetInEndSection":153,"text":"[The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8447318","offsetInEndSection":135,"text":"[Rheumatoid arthritis seropositive for the rheumatoid factor is linked to the protein tyrosine phosphatase nonreceptor 22-620W allele.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20707220","offsetInEndSection":99,"text":"[Functional polymorphisms of PTPN22 and FcgR genes in Tunisian patients with rheumatoid arthritis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16731003","offsetInEndSection":46,"text":"[PTPN22: setting thresholds for autoimmunity.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15790351","offsetInEndSection":77,"text":"[Pathways to gene identification in rheumatoid arthritis: PTPN22 and beyond.]","beginSection":"title"}],"id":"550316a6e9bde69634000029","body":"Which diseases have been associated with the PTPN22 620W allele","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14734054","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10717012","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18420707","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15972724","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10728347","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11515275","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10904833","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16793013","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15501438","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7774871"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16793013","offsetInEndSection":56,"text":"[Alpha B-crystallin mutation in dilated cardiomyopathy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15501438","offsetInEndSection":110,"text":"[Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18420707","offsetInEndSection":161,"text":"[Muscle creatine kinase deficiency triggers both actin depolymerization and desmin disorganization by advanced glycation end products in dilated cardiomyopathy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11515275","offsetInEndSection":39,"text":"[[Genetics of dilated cardiomyopathy].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10904833","offsetInEndSection":48,"text":"[Genetics of idiopathic dilated cardiomyopathy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10717012","offsetInEndSection":158,"text":"[A missense mutation in desmin tail domain linked to human dilated cardiomyopathy promotes cleavage of the head domain and abolishes its Z-disc localization.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14734054","offsetInEndSection":99,"text":"[Cardiomyocyte-specific desmin rescue of desmin null cardiomyopathy excludes vascular involvement.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15972724","offsetInEndSection":111,"text":"[Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10728347","offsetInEndSection":48,"text":"[The role of the cytoskeleton in heart failure.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7774871","offsetInEndSection":97,"text":"[[The extracellular matrix and cytoskeleton of the myocardium in cardiac inflammatory reaction].]","beginSection":"title"}],"id":"55031963e9bde6963400002a","body":"Is desmin an intermediate filament protein involved in Dilated Cardiomyopathy (DCM)","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24648004","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17448181","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19882941","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17515549","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26238820","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19556389","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22253364","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20096895","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26446289","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20456150"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17448181","offsetInEndSection":50,"text":"[Migraine and adiponectin: is there a connection?]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19556389","offsetInEndSection":68,"text":"[The role of the adipocytokines adiponectin and leptin in migraine.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24648004","offsetInEndSection":67,"text":"[Adiponectin and migraine: systematic review of clinical evidence.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26238820","offsetInEndSection":96,"text":"[Adiponectin and leptin levels in migraineurs in the Atherosclerosis Risk in Communities Study.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20456150","offsetInEndSection":67,"text":"[Migraine and obesity: epidemiology, mechanisms, and implications.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19882941","offsetInEndSection":59,"text":"[[Metabolic syndrome and prevention of migraine headache].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17515549","offsetInEndSection":78,"text":"[Obesity, migraine, and chronic migraine: possible mechanisms of interaction.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20096895","offsetInEndSection":123,"text":"[Serum concentrations of high-molecular weight adiponectin and their association with sex steroids in premenopausal women.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26446289","offsetInEndSection":117,"text":"[Lower levels of human milk adiponectin predict offspring weight for age: a study in a lean population of Filipinos.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22253364","offsetInEndSection":39,"text":"[paediatric obesity: a plausible link?]","beginSection":"title"}],"id":"55031d82e9bde6963400002c","body":"What is the association between adiponectin and migraine","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26478204","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26113998","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21540878","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25339210","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23307887","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17384640","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22451160","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22036172","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24745891","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25339215"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25339215","offsetInEndSection":79,"text":"[Clinical spectrum of 4H leukodystrophy caused by POLR3A and POLR3B mutations.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26113998","offsetInEndSection":85,"text":"[Endocrine Aspects of 4H Leukodystrophy: A Case Report and Review of the Literature.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23307887","offsetInEndSection":57,"text":"[An Indian boy with a novel leukodystrophy: 4H syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17384640","offsetInEndSection":101,"text":"[Recessive mutations in POLR1C cause a leukodystrophy by impairing biogenesis of RNA polymerase III.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21540878","offsetInEndSection":126,"text":"[Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26478204","offsetInEndSection":169,"text":"[Recessive Mutations in POLR3B Encoding RNA Polymerase III Subunit Causing Diffuse Hypomyelination in Patients with 4H Leukodystrophy with Polymicrogyria and Cataracts.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25339210","offsetInEndSection":88,"text":"[Neurogenic bladder and neuroendocrine abnormalities in Pol III-related leukodystrophy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22036172","offsetInEndSection":75,"text":"[Large exonic deletions in POLR3B gene cause POLR3-related leukodystrophy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24745891","offsetInEndSection":160,"text":"[Congenital genetic inborn errors of metabolism presenting as an adult or persisting into adulthood: neuroimaging in the more common or recognizable disorders.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22451160","offsetInEndSection":48,"text":"[More than hypomyelination in Pol-III disorder.]","beginSection":"title"}],"id":"550320cbe9bde6963400002d","body":"List symptoms of 4H leukodystrophy.","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17397038","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17397038","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12239580","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15384097","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16691592","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19019343","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19282698","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18327255","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8031530","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12876834"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17397038","offsetInEndSection":114,"text":"[Epistasis between RET and BBS mutations modulates enteric innervation and causes syndromic Hirschsprung disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8031530","offsetInEndSection":130,"text":"[Large-scale deletions and SMADIP1 truncating mutations in syndromic Hirschsprung disease with involvement of midline structures.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17397038","offsetInEndSection":96,"text":"[Epistatic interactions with a common hypomorphic RET allele in syndromic Hirschsprung disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18327255","offsetInEndSection":99,"text":"[Hypomorphic mutations in syndromic encephalocele genes are associated with Bardet-Biedl syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16691592","offsetInEndSection":113,"text":"[PHOX2B analysis in non-syndromic neuroblastoma cases shows novel mutations and genotype-phenotype associations.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19282698","offsetInEndSection":119,"text":"[Hirschsprung disease and congenital anomalies of the kidney and urinary tract (CAKUT): a novel syndromic association.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15384097","offsetInEndSection":124,"text":"[Ocular coloboma and high myopia with Hirschsprung disease associated with a novel ZFHX1B missense mutation and trisomy 21.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12239580","offsetInEndSection":93,"text":"[Hirschsprung, RET-SOX and beyond: the challenge of examining non-mendelian traits (Review).]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19019343","offsetInEndSection":26,"text":"[[Bardet-Biedl syndrome].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12876834","offsetInEndSection":43,"text":"[Bardet-Biedl syndrome and Usher syndrome.]","beginSection":"title"}],"id":"55032179e9bde6963400002e","body":"Are BBS mutations involved in syndromic Hirschsprung disease","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11578981","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16472910","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15935623","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12742871","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26249259","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17026953","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24212719","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12270000","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15108187","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25369905"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12270000","offsetInEndSection":77,"text":"[Personality traits and the risk for Parkinson disease: a prospective study.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15935623","offsetInEndSection":158,"text":"[Familial risk for mood disorder and the personality risk factor, neuroticism, interact in their association with frontolimbic serotonin 2A receptor binding.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25369905","offsetInEndSection":58,"text":"[Personality and risk for postpartum depressive symptoms.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15108187","offsetInEndSection":139,"text":"[Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11578981","offsetInEndSection":72,"text":"[Anxious personality predicts an increased risk of Parkinson's disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16472910","offsetInEndSection":115,"text":"[Association between dopamine D4 receptor (DRD4) exon III polymorphism and Neuroticism in the Japanese population.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24212719","offsetInEndSection":101,"text":"[Association between extraversion personality and abnormal glucose regulation in young Korean women.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12742871","offsetInEndSection":150,"text":"[The genetic association between personality and major depression or bipolar disorder. A polygenic score analysis using genome-wide association data.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26249259","offsetInEndSection":128,"text":"[Personality Correlates of Midlife Cardiometabolic Risk: The Explanatory Role of Higher-Order Factors of the Five-Factor Model.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17026953","offsetInEndSection":190,"text":"[Neuroticism-related personality traits are related to symptom severity in patients with premenstrual dysphoric disorder and to the serotonin transporter gene-linked polymorphism 5-HTTPLPR.]","beginSection":"title"}],"id":"550324d7e9bde6963400002f","body":"What is the association between personality trait of neuroticism and risk for Alzheimer's disease","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14512967","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10360766","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15234148","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14512967","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17578274","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9183252","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14517542","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25186864","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10439962","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17195938"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15234148","offsetInEndSection":85,"text":"[Ocular features of the congenital cataracts facial dysmorphism neuropathy syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17195938","offsetInEndSection":117,"text":"[Congenital cataracts facial dysmorphism neuropathy (CCFDN) syndrome: a rare cause of parainfectious rhabdomyolysis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14512967","offsetInEndSection":61,"text":"[Homozygosity mapping of Marinesco-Sjögren syndrome to 5q31.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25186864","offsetInEndSection":54,"text":"[Long-term follow-up in patients with CCFDN syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14517542","offsetInEndSection":158,"text":"[Partial deficiency of the C-terminal-domain phosphatase of RNA polymerase II is associated with congenital cataracts facial dysmorphism neuropathy syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9183252","offsetInEndSection":136,"text":"[Cognitive Impairment and Brain Imaging Characteristics of Patients with Congenital Cataracts, Facial Dysmorphism, Neuropathy Syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10439962","offsetInEndSection":128,"text":"[Congenital cataracts facial dysmorphism neuropathy (CCFDN) syndrome: a novel developmental disorder in Gypsies maps to 18qter.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17578274","offsetInEndSection":93,"text":"[[Congenital cataracts facial dysmorphism neuropathy syndrome--first Hungarian case report].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10360766","offsetInEndSection":161,"text":"[Congenital cataracts facial dysmorphism neuropathy syndrome, a novel complex genetic disease in Balkan Gypsies: clinical and electrophysiological observations.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14512967","offsetInEndSection":53,"text":"[Congenital cataracts-facial dysmorphism-neuropathy.]","beginSection":"title"}],"id":"5503263fe9bde69634000030","body":"List three major features of the CCFDN syndrome.","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27239922","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27870908","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11305853","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22034610","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18553094","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12361187","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20214466","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18516966","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17906884","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26908625"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12361187","offsetInEndSection":95,"text":"[NT-proBNP, blood pressure, and cognitive decline in the oldest old: The Leiden 85-plus Study.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18516966","offsetInEndSection":89,"text":"[[Clinical utility of NT-proBNP, a new biomarker of cardiac function and heart failure].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26908625","offsetInEndSection":114,"text":"[Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20214466","offsetInEndSection":117,"text":"[Predictive value of NT-proBNP in vascular surgery patients with COPD and normal left ventricular systolic function.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11305853","offsetInEndSection":136,"text":"[Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetes.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18553094","offsetInEndSection":85,"text":"[Evaluation of postmortem measurement of NT-proBNP as a marker for cardiac function.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22034610","offsetInEndSection":131,"text":"[Log-transformation improves the prognostic value of serial NT-proBNP levels in apparently stable pulmonary arterial hypertension.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27239922","offsetInEndSection":189,"text":"[[N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17906884","offsetInEndSection":109,"text":"[N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27870908","offsetInEndSection":118,"text":"[N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for Loss of Muscle Mass in Prevalent Hemodialysis Patients.]","beginSection":"title"}],"id":"55032785e9bde69634000031","body":"What is the association between NT-proBNP and cognitive function","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24217890","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25681309","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27302309","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23908149","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27025857","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25783747","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26960334","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26709572","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23887589","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27571882"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27302309","offsetInEndSection":117,"text":"[Concurrent TERT promoter and BRAF V600E mutation in epithelioid glioblastoma and concomitant low-grade astrocytoma.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25681309","offsetInEndSection":90,"text":"[TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27571882","offsetInEndSection":166,"text":"[Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24217890","offsetInEndSection":65,"text":"[TERT promoter mutations in primary and secondary glioblastomas.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23887589","offsetInEndSection":56,"text":"[Frequency of TERT promoter mutations in human cancers.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26960334","offsetInEndSection":60,"text":"[High incidence of TERT mutation in brain tumor cell lines.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26709572","offsetInEndSection":89,"text":"[Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23908149","offsetInEndSection":139,"text":"[The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25783747","offsetInEndSection":185,"text":"[Molecular classification of diffuse cerebral WHO grade II\/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27025857","offsetInEndSection":68,"text":"[Radiotherapy plus concomitant temozolomide in primary gliosarcoma.]","beginSection":"title"}],"id":"55032bbfe9bde69634000032","body":"Is there an association between TERT promoter mutation and survival of glioblastoma patients","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25285145","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24935165","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15003307","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8295771","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9062162","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15034472","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2277266","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9127290","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21061568","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16840920"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8295771","offsetInEndSection":63,"text":"[[Tumor-associated myasthenia gravis and myasthenia syndrome].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9062162","offsetInEndSection":82,"text":"[Myasthenia gravis associated with malignant mixed Mullerian tumor of the uterus.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15034472","offsetInEndSection":35,"text":"[[Seronegative myasthenia gravis].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25285145","offsetInEndSection":84,"text":"[Osteoporosis with vertebral fractures associated with pregnancy: two case reports.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2277266","offsetInEndSection":92,"text":"[Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24935165","offsetInEndSection":51,"text":"[Exacerbation of myasthenia gravis by alendronate.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16840920","offsetInEndSection":53,"text":"[[Myasthenia gravis and hyperthyroidism: two cases].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21061568","offsetInEndSection":72,"text":"[[Dysphagia and dysarthria surgery for advanced-age myasthenia gravis].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15003307","offsetInEndSection":86,"text":"[Bone density in myasthenia gravis patients receiving long-term prednisolone therapy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9127290","offsetInEndSection":77,"text":"[Clinical forms of acquired myasthenia gravis in dogs: 25 cases (1988-1995).]","beginSection":"title"}],"id":"55032d8be9bde69634000033","body":"Is myasthenia gravis associated with osteoporosis","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15798614","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25561948","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12763349","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17250509","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19029569","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16100487","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24891488","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15798614","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20691943","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26557182"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12763349","offsetInEndSection":32,"text":"[Dyke-Davidoff-Masson syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19029569","offsetInEndSection":32,"text":"[Dyke-Davidoff-Masson syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15798614","offsetInEndSection":57,"text":"[[Dyke-Davidoff-Masson syndrome: a report of two cases].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25561948","offsetInEndSection":69,"text":"[Dyke-Davidoff-Masson Syndrome- a rare cause of refractory epilepsy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17250509","offsetInEndSection":60,"text":"[Dyke-Davidoff-Masson syndrome: Classical imaging findings.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24891488","offsetInEndSection":63,"text":"[Dyke-Davidoff-Masson syndrome: a clinicoradiological amalgam.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16100487","offsetInEndSection":64,"text":"[Positron emission tomography in Dyke-Davidoff-Masson syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20691943","offsetInEndSection":66,"text":"[Facial capillary malformation and Dyke-Davidoff-Masson syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15798614","offsetInEndSection":126,"text":"[Dyke-Davidoff-Masson syndrome: case report of fetal unilateral ventriculomegaly and hypoplastic left middle cerebral artery.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26557182","offsetInEndSection":145,"text":"[Magnetic resonance imaging depiction of acquired Dyke-Davidoff-Masson syndrome with crossed cerebro-cerebellar diaschisis: Report of two cases.]","beginSection":"title"}],"id":"55032e65e9bde69634000034","body":"What is the characteristic feature of the Dyke-Davidoff-Masson syndrome.","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16360270","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20573757","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22278333","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20164785","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20188075","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20173082","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21221171","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21323397","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21457247","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19796656"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20573757","offsetInEndSection":136,"text":"[Characterization of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20188075","offsetInEndSection":121,"text":"[Mapping the CGRP receptor ligand binding domain: tryptophan-84 of RAMP1 is critical for agonist and antagonist binding.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20173082","offsetInEndSection":149,"text":"[Single- and multiple-dose pharmacokinetics and tolerability of telcagepant, an oral calcitonin gene-related peptide receptor antagonist, in adults.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20164785","offsetInEndSection":178,"text":"[Comparison of the vasoconstrictor effects of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) and zolmitriptan in human isolated coronary arteries.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21323397","offsetInEndSection":91,"text":"[Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21457247","offsetInEndSection":97,"text":"[Excellent tolerability but relatively low initial clinical efficacy of telcagepant in migraine.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19796656","offsetInEndSection":124,"text":"[The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21221171","offsetInEndSection":126,"text":"[The Dose Proportionality of Telcagepant after Administration of Single Oral and Intravenous Doses in Healthy Adult Subjects.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22278333","offsetInEndSection":119,"text":"[A randomized, placebo-controlled study of the effects of telcagepant on exercise time in patients with stable angina.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16360270","offsetInEndSection":55,"text":"[Acute migraine therapy: new drugs and new approaches.]","beginSection":"title"}],"id":"55032efde9bde69634000035","body":"Which receptor is targeted by telcagepant","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7969211","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23634190","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21465551","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7568632","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11866252","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22940695","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11254789","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19720723","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9298329","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2046475"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7969211","offsetInEndSection":104,"text":"[Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19720723","offsetInEndSection":162,"text":"[Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21465551","offsetInEndSection":186,"text":"[The selective mu-opioid receptor antagonist ADL5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in MPTP-lesioned macaque model of Parkinson's disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23634190","offsetInEndSection":91,"text":"[Diagnosis and treatment of impulse control disorders in patients with movement disorders.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11866252","offsetInEndSection":134,"text":"[Contingency management to enhance naltrexone treatment of opioid dependence: a randomized clinical trial of reinforcement magnitude.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22940695","offsetInEndSection":88,"text":"[Effect of chronic l-DOPA treatment on 5-HT(1A) receptors in parkinsonian monkey brain.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7568632","offsetInEndSection":106,"text":"[Morphine and naltrexone modulate D2 but not D1 receptor induced motor behavior in MPTP-lesioned monkeys.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2046475","offsetInEndSection":125,"text":"[Opiate antagonist binding sites in discrete brain regions of spontaneously hypertensive and normotensive Wistar-Kyoto rats.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11254789","offsetInEndSection":59,"text":"[High dose naltrexone for dyskinesias induced by levodopa.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9298329","offsetInEndSection":111,"text":"[Compliance to naltrexone treatment after ultra-rapid opiate detoxification: an open label naturalistic study.]","beginSection":"title"}],"id":"55033064e9bde69634000036","body":"What is  the clinical value of naltrexone in Parkinson's disease patients","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22155803","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26217638","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21487978","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21059529","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22311713","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23809937","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8467424","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24704584","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20351675","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18400414"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21487978","offsetInEndSection":149,"text":"[[\"Chronic cerebrospinal venous insufficiency\" in multiple sclerosis - is multiple sclerosis a disease of the cerebrospinal venous outflow system?].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8467424","offsetInEndSection":122,"text":"[Venous angioplasty in multiple sclerosis: neurological outcome at two years in a cohort of relapsing-remitting patients.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26217638","offsetInEndSection":85,"text":"[Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis: A Failed Concept.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22155803","offsetInEndSection":108,"text":"[Endovascular treatment of patients with chronic cerebrospinal venous insufficiency and multiple sclerosis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22311713","offsetInEndSection":103,"text":"[Chronic cerebrospinal venous insufficiency as a cause of multiple sclerosis: controversy and reality.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20351675","offsetInEndSection":144,"text":"[Chronic cerebro-spinal venous insufficiency: report of transcranial magnetic stimulation follow-up study in a patient with multiple sclerosis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18400414","offsetInEndSection":145,"text":"[Hypothetical molecular mechanisms by which local iron overload facilitates the development of venous leg ulcers and multiple sclerosis lesions.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23809937","offsetInEndSection":142,"text":"[Spiral vein graft for internal jugular bypass in a patient with multiple sclerosis and suspected chronic cerebrospinal venous insufficiency.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24704584","offsetInEndSection":165,"text":"[Bilateral surgical reconstruction for internal jugular veins disease in patients with chronic cerebrospinal venous insufficiency and associated multiple sclerosis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21059529","offsetInEndSection":43,"text":"[Multiple sclerosis - a vascular etiology?]","beginSection":"title"}],"id":"550331abe9bde69634000037","body":"What is the role of venous angioplasty in multiple sclerosis","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20722665","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/403481","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26312202","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26133327","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17105462","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8753132","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8243377","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19191339","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12040893","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21351810"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17105462","offsetInEndSection":97,"text":"[The natural history of myoclonic astatic epilepsy (Doose syndrome) and Lennox-Gastaut syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20722665","offsetInEndSection":68,"text":"[Doose syndrome (myoclonic-astatic epilepsy): 40 years of progress.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8243377","offsetInEndSection":30,"text":"[The Lennox-Gastaut syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26133327","offsetInEndSection":84,"text":"[Three siblings with multiform seizures: An unusual presentation of Doose syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21351810","offsetInEndSection":52,"text":"[Management of seizures in Lennox-Gastaut syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8753132","offsetInEndSection":132,"text":"[[A successful treatment with a continuous intravenous lidocaine for a cluster of minor seizures in a patient with Doose syndrome].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12040893","offsetInEndSection":106,"text":"[Does the effectiveness of the ketogenic diet in different epilepsies yield insights into its mechanisms?]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26312202","offsetInEndSection":114,"text":"[Novel way to investigate evolution of children refractory epilepsy by complexity metrics in massive information.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/403481","offsetInEndSection":106,"text":"[Genetic factors in childhood epilepsy with focal sharp waves. II. EEG findings in patients and siblings.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19191339","offsetInEndSection":123,"text":"[Two novel CLCN2 mutations accelerating chloride channel deactivation are associated with idiopathic generalized epilepsy.]","beginSection":"title"}],"id":"550342a8f8aee20f27000002","body":"Which is the major symptom of the Doose syndrome","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19754359","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10085141","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1700866","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17942932","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8625307","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12202786","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25625231","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27790245","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10404636","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6816671"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6816671","offsetInEndSection":68,"text":"[Dynein and Star interact in EGFR signaling and ligand trafficking.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8625307","offsetInEndSection":134,"text":"[Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10085141","offsetInEndSection":123,"text":"[Effect of epidermal growth factor receptor internalization on regulation of the phospholipase C-gamma1 signaling pathway.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27790245","offsetInEndSection":148,"text":"[Associations of mRNA:microRNA for the Shared Downstream Molecules of EGFR and Alternative Tyrosine Kinase Receptors in Non-small Cell Lung Cancer.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1700866","offsetInEndSection":165,"text":"[Analysis of receptor signaling pathways by mass spectrometry: identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25625231","offsetInEndSection":110,"text":"[Chrysin, baicalein and galangin are indirect activators of the human constitutive androstane receptor (CAR).]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10404636","offsetInEndSection":15,"text":"[EGF receptor.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19754359","offsetInEndSection":139,"text":"[Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17942932","offsetInEndSection":140,"text":"[Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12202786","offsetInEndSection":89,"text":"[Epidermal growth factor receptor dependence in human tumors: more than just expression?]","beginSection":"title"}],"id":"55046d5ff8aee20f27000007","body":"List signaling molecules (ligands) that interact with the receptor EGFR","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22697347","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22697346","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26567105","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25589730","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26872075","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21206091","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20098685","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26879107","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20521444","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23986815"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26872075","offsetInEndSection":68,"text":"[Walking the tightrope: proteostasis and neurodegenerative disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22697346","offsetInEndSection":75,"text":"[Can correcting the ΔF508-CFTR proteostasis-defect rescue CF lung disease?]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26567105","offsetInEndSection":48,"text":"[Proteostasis in pediatric pulmonary pathology.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20098685","offsetInEndSection":65,"text":"[Proteostasis: a new therapeutic paradigm for pulmonary disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25589730","offsetInEndSection":80,"text":"[Mechanisms of molecular mimicry involving the microbiota in neurodegeneration.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21206091","offsetInEndSection":93,"text":"[Proteostasis and movement disorders: Parkinson's disease and amyotrophic lateral sclerosis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23986815","offsetInEndSection":90,"text":"[Chaperone-assisted proteostasis is essential for mechanotransduction in mammalian cells.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22697347","offsetInEndSection":96,"text":"[Therapeutic strategies to correct proteostasis-imbalance in chronic obstructive lung diseases.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20521444","offsetInEndSection":136,"text":"[Mitochondrial dysfunction, proteotoxicity, and aging: causes or effects, and the possible impact of NAD+-controlled protein glycation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26879107","offsetInEndSection":124,"text":"[Rescue of defective ATP8B1 trafficking by CFTR correctors as a therapeutic strategy for familial intrahepatic cholestasis.]","beginSection":"title"}],"id":"55048939f8aee20f27000009","body":"Explain the concept proteostasis.","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14500979","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17799386","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25062283","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24156614","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27320398","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23961534","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18612647","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22014085","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7588569","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15888409"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24156614","offsetInEndSection":61,"text":"[Dating human bone: is racemization dating species-specific?]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25062283","offsetInEndSection":89,"text":"[Collagen Fingerprinting: A New Screening Technique for Radiocarbon Dating Ancient Bone.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23961534","offsetInEndSection":125,"text":"[Identification of Dactylopius cochineal species with high-performance liquid chromatography and multivariate data analysis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22014085","offsetInEndSection":112,"text":"[Identification of animal glue species in artworks using proteomics: application to a 18th century gilt sample.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14500979","offsetInEndSection":58,"text":"[Amazon archaelogy. 'Pristine' forest teemed with people.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7588569","offsetInEndSection":74,"text":"[Mineral-bound noncollagenous proteins in archaeological human skeletons.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17799386","offsetInEndSection":52,"text":"[ARCHAELOGY: A Victim of the Black Sea Flood Found.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18612647","offsetInEndSection":61,"text":"[Ivory identification by DNA profiling of cytochrome b gene.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27320398","offsetInEndSection":162,"text":"[Skeletal idiopathic osteosclerosis helps to perform personal identification of unknown decedents: A novel contribution from anatomical variants through CT scan.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15888409","offsetInEndSection":156,"text":"[Preserved Proteins from Extinct Bison latifrons Identified by Tandem Mass Spectrometry; Hydroxylysine Glycosides are a Common Feature of Ancient Collagen.]","beginSection":"title"}],"id":"55054f8af73303d458000002","body":"Which bone protein is used in archaelogy for dating and species identification","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26926424","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10878807","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23581475","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22570270","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17470788","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9824166","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12654245","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11846609","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9744860","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12646216"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12654245","offsetInEndSection":87,"text":"[Pirh2 E3 ubiquitin ligase targets DNA polymerase eta for 20S proteasomal degradation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10878807","offsetInEndSection":108,"text":"[Erioflorin stabilizes the tumor suppressor Pdcd4 by inhibiting its interaction with the E3-ligase β-TrCP1.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17470788","offsetInEndSection":114,"text":"[Smad ubiquitylation regulatory factor 1\/2 (Smurf1\/2) promotes p53 degradation by stabilizing the E3 ligase MDM2.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22570270","offsetInEndSection":162,"text":"[SCYL1 binding protein 1 promotes the ubiquitin-dependent degradation of Pirh2 and has tumor-suppressive function in the development of hepatocellular carcinoma.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12646216","offsetInEndSection":126,"text":"[A label-free quantitative proteomics strategy to identify E3 ubiquitin ligase substrates targeted to proteasome degradation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23581475","offsetInEndSection":75,"text":"[c-Abl phosphorylates E6AP and regulates its E3 ubiquitin ligase activity.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9824166","offsetInEndSection":79,"text":"[Auto-ubiquitination of Mdm2 enhances its substrate ubiquitin ligase activity.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26926424","offsetInEndSection":103,"text":"[RNF12 promotes p53-dependent cell growth suppression and apoptosis by targeting MDM2 for destruction.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11846609","offsetInEndSection":61,"text":"[The double life of MULE in preeclamptic and IUGR placentae.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9744860","offsetInEndSection":84,"text":"[Mdm2 RING mutation enhances p53 transcriptional activity and p53-p300 interaction.]","beginSection":"title"}],"id":"55058af6f73303d458000004","body":"Which protein is the E3-ubiquitin ligase that targets the tumor suppressor p53 for proteasomal degradation","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25893736","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19029981","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15698420","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11756242","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11038295","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22500497","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17495519","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25076330","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24426788","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25594310"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22500497","offsetInEndSection":108,"text":"[Molecular pathogenesis of vestibular schwannomas: insights for the development of novel medical therapies.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19029981","offsetInEndSection":82,"text":"[Rational combination of dual PI3K\/mTOR blockade and Bcl-2\/-xL inhibition in AML.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25893736","offsetInEndSection":122,"text":"[A carbazole alkaloid deactivates mTOR through the suppression of rictor and that induces apoptosis in lung cancer cells.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15698420","offsetInEndSection":128,"text":"[Is There a Role for Mammalian Target of Rapamycin Inhibition in Renal Failure due to Mesangioproliferative Nephrotic Syndrome?]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11756242","offsetInEndSection":86,"text":"[Dual Inhibition of MEK and PI3K Pathway in KRAS and BRAF Mutated Colorectal Cancers.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11038295","offsetInEndSection":54,"text":"[Ewing's sarcoma: overcoming the therapeutic plateau.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17495519","offsetInEndSection":110,"text":"[Signal-dependent control of autophagy and cell death in colorectal cancer cell: the role of the p38 pathway.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25076330","offsetInEndSection":84,"text":"[Chemotherapy and metformin in pancreatic adenocarcinoma and neuroendocrine tumors.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24426788","offsetInEndSection":84,"text":"[Developments in Burkitt's lymphoma: novel cooperations in oncogenic MYC signaling.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25594310","offsetInEndSection":87,"text":"[Rheb promotes cancer cell survival through p27Kip1-dependent activation of autophagy.]","beginSection":"title"}],"id":"5505a587f73303d458000005","body":"What does mTOR stands for","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15258597","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22017684","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19013662","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18801697","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21338572","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20135644","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27317487","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24212825","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23810968","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18381446"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19013662","offsetInEndSection":106,"text":"[IGF-I, EGF, and sex steroids regulate autophagy in bovine mammary epithelial cells via the mTOR pathway.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18801697","offsetInEndSection":62,"text":"[mTOR regulates autophagy-associated genes downstream of p73.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27317487","offsetInEndSection":76,"text":"[ESAT6 inhibits autophagy flux and promotes BCG proliferation through MTOR.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15258597","offsetInEndSection":87,"text":"[TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18381446","offsetInEndSection":100,"text":"[Mammalian target of rapamycin and S6 kinase 1 positively regulate 6-thioguanine-induced autophagy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21338572","offsetInEndSection":108,"text":"[Diacylglycerol kinase inhibitor R59022-induced autophagy and apoptosis in the neuronal cell line NG108-15.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24212825","offsetInEndSection":37,"text":"[Regulation of autophagy by kinases.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22017684","offsetInEndSection":146,"text":"[Protective role of AMP-activated protein kinase-evoked autophagy on an in vitro model of ischemia\/reperfusion-induced renal tubular cell injury.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23810968","offsetInEndSection":161,"text":"[mTOR inactivation by ROS-JNK-p53 pathway plays an essential role in psedolaric acid B induced autophagy-dependent senescence in murine fibrosarcoma L929 cells.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20135644","offsetInEndSection":198,"text":"[Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMP-activated protein kinase\/mammalian target of rapamycin pathway.]","beginSection":"title"}],"id":"5505ad7ff73303d458000007","body":"Does the protein mTOR regulate autophagy","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15781609","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24899720","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20659891","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23827240","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23810837","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24070477","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19898463","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11283351","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17182613","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26655035"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19898463","offsetInEndSection":25,"text":"[Autophagy in infection.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20659891","offsetInEndSection":116,"text":"[The Autophagy Database: an all-inclusive information resource on autophagy that provides nourishment for research.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23827240","offsetInEndSection":128,"text":"[Autophagy Regulatory Network - a systems-level bioinformatics resource for studying the mechanism and regulation of autophagy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24070477","offsetInEndSection":66,"text":"[Role of autophagy in cancer prevention, development and therapy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11283351","offsetInEndSection":112,"text":"[Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15781609","offsetInEndSection":155,"text":"[Autophagy is a prosurvival mechanism in cells expressing an autosomal dominant familial neurohypophyseal diabetes insipidus mutant vasopressin transgene.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23810837","offsetInEndSection":124,"text":"[Complex regulation of autophagy in cancer - integrated approaches to discover the networks that hold a double-edged sword.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24899720","offsetInEndSection":170,"text":"[Rapamycin and chloroquine: the in vitro and in vivo effects of autophagy-modifying drugs show promising results in valosin containing protein multisystem proteinopathy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26655035","offsetInEndSection":171,"text":"[Mitochondrial impairment, apoptosis and autophagy in a rat brain as immediate and long-term effects of perinatal phencyclidine treatment - influence of restraint stress.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17182613","offsetInEndSection":77,"text":"[Excitotoxic glutamate insults block autophagic flux in hippocampal neurons.]","beginSection":"title"}],"id":"5505b9ff8e1671127b000001","body":"List markers for autophagy.","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15268862","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24331524","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18030348","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22125063","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21413931","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27016480","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15718470","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11185526","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18614546","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15772076"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15718470","offsetInEndSection":88,"text":"[The mTOR (mammalian target of rapamycin) kinase maintains integrity of mTOR complex 2.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18030348","offsetInEndSection":41,"text":"[mTOR complex 2 signaling and functions.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15268862","offsetInEndSection":81,"text":"[Identification of Protor as a novel Rictor-binding component of mTOR complex-2.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18614546","offsetInEndSection":180,"text":"[Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21413931","offsetInEndSection":86,"text":"[Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27016480","offsetInEndSection":120,"text":"[Basal mTORC2 activity and expression of its components display diurnal variation in mouse perivascular adipose tissue.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22125063","offsetInEndSection":74,"text":"[Detection of cytoplasmic and nuclear functions of mTOR by fractionation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15772076","offsetInEndSection":106,"text":"[Leucine stimulates protein synthesis in skeletal muscle of neonatal pigs by enhancing mTORC1 activation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11185526","offsetInEndSection":138,"text":"[Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial carcinoma.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24331524","offsetInEndSection":160,"text":"[LST8 level controls basal p70 S6 kinase and Akt phosphorylations, and mTORC1 and mTORC2 negatively regulate each other by competing for association with LST8.]","beginSection":"title"}],"id":"5505c9008e1671127b000002","body":"List the components of mTOR Complex 2 (mTORC2).","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1725490","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16837174","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10963381","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7527050","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14533737","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1709103","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7693709","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4106435","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12122445","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27618011"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7693709","offsetInEndSection":170,"text":"[Diversity of intermediate filament structure. Evidence that the alignment of coiled-coil molecules in vimentin is different from that in keratin intermediate filaments.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16837174","offsetInEndSection":98,"text":"[Keratin-rhamnolipids and keratin-sodium dodecyl sulfate interactions at the air\/water interface.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14533737","offsetInEndSection":149,"text":"[The cell-cell junctions of mammalian testes: I. The adhering junctions of the seminiferous epithelium represent special differentiation structures.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1725490","offsetInEndSection":227,"text":"[Analysis of the mechanism of assembly of mouse keratin 1\/keratin 10 intermediate filaments in vitro suggests that intermediate filaments are built from multiple oligomeric units rather than a unique tetrameric building block.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4106435","offsetInEndSection":136,"text":"[Fine structure of the developing epidermis in the embryo of the American alligator (Alligator mississippiensis, Crocodilia, Reptilia).]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10963381","offsetInEndSection":107,"text":"[Keratin 14 immunoreactive cells in pleomorphic adenomas and adenoid cystic carcinomas of salivary glands.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27618011","offsetInEndSection":124,"text":"[Comparative Study of Ultrasonication-Induced and Naturally Self-Assembled Silk Fibroin-Wool Keratin Hydrogel Biomaterials.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7527050","offsetInEndSection":108,"text":"[Function of type I and type II keratin head domains: their role in dimer, tetramer and filament formation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1709103","offsetInEndSection":166,"text":"[Morphological differentiation of hybrids of human mammary epithelial cell lines is dominant and correlates with the pattern of expression of intermediate filaments.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12122445","offsetInEndSection":153,"text":"[Golgi-associated filament networks in duct epithelial cells of rabbit submandibular glands: immunohistochemical light and electron microscopic studies.]","beginSection":"title"}],"id":"5505db6a8e1671127b000003","body":"What are the structures formed when keratin molecules come together","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22807358","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22218331","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21316059","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20073204","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17256977","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21122866","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20441989","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18428181","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23073287","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23685016"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23685016","offsetInEndSection":80,"text":"[Hydrophilic interaction chromatography (HILIC) in the analysis of antibiotics.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23073287","offsetInEndSection":165,"text":"[Evaluation of hydrophilic interaction chromatography (HILIC) versus C\u2081\u2088 reversed-phase chromatography for targeted quantification of peptides by mass spectrometry.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17256977","offsetInEndSection":80,"text":"[Evaluation and optimization of ZIC-HILIC-RP as an alternative MudPIT strategy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21122866","offsetInEndSection":119,"text":"[Comparison of hydrophilic-interaction, reversed-phase and porous graphitic carbon chromatography for glycan analysis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21316059","offsetInEndSection":129,"text":"[Application of hydrophilic interaction chromatography for the analysis of polar contaminants in food and environmental samples.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20073204","offsetInEndSection":142,"text":"[[Stationary phases for hydrophilic interaction liquid chromatography and their applications in separation of traditional Chinese medicines].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22218331","offsetInEndSection":270,"text":"[Combination of off-line two-dimensional hydrophilic interaction liquid chromatography for polar fraction and two-dimensional hydrophilic interaction liquid chromatography×reversed-phase liquid chromatography for medium-polar fraction in a traditional Chinese medicine.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18428181","offsetInEndSection":152,"text":"[Stationary phases for hydrophilic interaction chromatography, their characterization and implementation into multidimensional chromatography concepts.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20441989","offsetInEndSection":149,"text":"[Orthogonal separation on one beta-cyclodextrin column by switching reversed-phase liquid chromatography and hydrophilic interaction chromatography.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22807358","offsetInEndSection":179,"text":"[Fully automatable two-dimensional hydrophilic interaction liquid chromatography-reversed phase liquid chromatography with online tandem mass spectrometry for shotgun proteomics.]","beginSection":"title"}],"id":"5505edac8e1671127b000005","body":"What kind of chromatography is HILIC","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24447065","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24986539","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27123950","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25823410","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19722210","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2716847","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19913576","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21873015","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14718574","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27503675"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27123950","offsetInEndSection":82,"text":"[Six alternative proteases for mass spectrometry-based proteomics beyond trypsin.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19913576","offsetInEndSection":93,"text":"[Accelerated digestion for high-throughput proteomics analysis of whole bacterial proteomes.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24986539","offsetInEndSection":103,"text":"[Influence of the digestion technique, protease, and missed cleavage peptides in protein quantitation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24447065","offsetInEndSection":147,"text":"[Dual matrix-based immobilized trypsin for complementary proteolytic digestion and fast proteomics analysis with higher protein sequence coverage.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27503675","offsetInEndSection":78,"text":"[How to talk about protein-level false discovery rates in shotgun proteomics.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14718574","offsetInEndSection":99,"text":"[The human plasma proteome: a nonredundant list developed by combination of four separate sources.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25823410","offsetInEndSection":28,"text":"[Proteomics beyond trypsin.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2716847","offsetInEndSection":76,"text":"[Expanding proteome coverage with orthogonal-specificity α-lytic proteases.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19722210","offsetInEndSection":94,"text":"[Rapid and efficient proteolysis for proteomic analysis by protease-immobilized microreactor.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21873015","offsetInEndSection":59,"text":"[Critical assessment of accelerating trypsination methods.]","beginSection":"title"}],"id":"5505eed08e1671127b000006","body":"List the main proteases used for sample digestion in proteomics.","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8611507","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12374792","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12573538","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17510962","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6296814","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7891112","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9843442","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14633703","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7510704","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9188695"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12374792","offsetInEndSection":133,"text":"[Usage of tautomycetin, a novel inhibitor of protein phosphatase 1 (PP1), reveals that PP1 is a positive regulator of Raf-1 in vivo.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8611507","offsetInEndSection":124,"text":"[Multiple structural elements define the specificity of recombinant human inhibitor-1 as a protein phosphatase-1 inhibitor.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9843442","offsetInEndSection":116,"text":"[Identification and characterization of the human HCG V gene product as a novel inhibitor of protein phosphatase-1.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9188695","offsetInEndSection":123,"text":"[Conversion of protein phosphatase 1 catalytic subunit to a Mn(2+)-dependent enzyme impairs its regulation by inhibitor 1.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14633703","offsetInEndSection":185,"text":"[The heat shock protein 90 inhibitor geldanamycin and the ErbB inhibitor ZD1839 promote rapid PP1 phosphatase-dependent inactivation of AKT in ErbB2 overexpressing breast cancer cells.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7891112","offsetInEndSection":96,"text":"[Protein phosphatase-1 regulates outward K+ currents in sensory neurons of Aplysia californica.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7510704","offsetInEndSection":92,"text":"[Dephosphorylation of the small heat shock protein Hsp27 in vivo by protein phosphatase 2A.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6296814","offsetInEndSection":141,"text":"[Growth arrest and DNA damage-inducible protein GADD34 assembles a novel signaling complex containing protein phosphatase 1 and inhibitor 1.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12573538","offsetInEndSection":107,"text":"[Dopamine transporters are dephosphorylated in striatal homogenates and in vitro by protein phosphatase 1.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17510962","offsetInEndSection":66,"text":"[Structural and biochemical characterization of inhibitor-1alpha.]","beginSection":"title"}],"id":"550618f58e1671127b000007","body":"Which protein is the main inhibitor of protein phosphatase 1 (PP1)","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9350040","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1849481","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2855362","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2847012","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16774736","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1309982","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3015916","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2844819","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9646865","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27262704"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1849481","offsetInEndSection":115,"text":"[Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3015916","offsetInEndSection":94,"text":"[A phospholamban protein phosphatase activity associated with cardiac sarcoplasmic reticulum.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9646865","offsetInEndSection":94,"text":"[The structure and mechanism of protein phosphatases: insights into catalysis and regulation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9350040","offsetInEndSection":115,"text":"[Protein phosphorylation in rat cardiac microsomes: effects of inhibitors of protein kinase A and of phosphatases.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2847012","offsetInEndSection":116,"text":"[The role of protein kinases and protein phosphatases in the regulation of cardiac sarcoplasmic reticulum function.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2855362","offsetInEndSection":73,"text":"[Regulation of cardiac sarcoplasmic reticulum function by phospholamban.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2844819","offsetInEndSection":85,"text":"[Purification and characterization of phospholamban phosphatase from cardiac muscle.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27262704","offsetInEndSection":76,"text":"[Unique carbohydrate binding platforms employed by the glucan phosphatases.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1309982","offsetInEndSection":98,"text":"[The phospholamban phosphatase associated with cardiac sarcoplasmic reticulum is a type 1 enzyme.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16774736","offsetInEndSection":114,"text":"[Role of calcineurin and protein phosphatase-2A in the regulation of phosphatase inhibitor-1 in cardiac myocytes.]","beginSection":"title"}],"id":"5506a7a48e1671127b000008","body":"Which protein phosphatases have been found to dephosphorylate phospholamban","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14660663","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15764845","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12491791","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16467501","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16003546","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16960421","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15231867","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17310075","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8423058","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21774754"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8423058","offsetInEndSection":135,"text":"[SEA0400, a specific inhibitor of the Na+-Ca2+ exchanger, attenuates sodium nitroprusside-induced apoptosis in cultured rat microglia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15764845","offsetInEndSection":167,"text":"[Functional proteins involved in regulation of intracellular Ca(2+) for drug development: pharmacology of SEA0400, a specific inhibitor of the Na(+)-Ca(2+) exchanger.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16003546","offsetInEndSection":135,"text":"[Unique excitation-contraction characteristics of mouse myocardium as revealed by SEA0400, a specific inhibitor of Na+-Ca2+ exchanger.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17310075","offsetInEndSection":137,"text":"[Involvement of the Na+\/Ca2+ exchanger in ouabain-induced inotropy and arrhythmogenesis in guinea-pig myocardium as revealed by SEA0400.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16960421","offsetInEndSection":161,"text":"[Inhibition by SEA0400, a selective inhibitor of Na+\/Ca2+ exchanger, of Na+ -dependent Ca2+ uptake and catecholamine release in bovine adrenal chromaffin cells.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16467501","offsetInEndSection":108,"text":"[Vascular Na+\/Ca2+ exchanger: implications for the pathogenesis and therapy of salt-dependent hypertension.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21774754","offsetInEndSection":118,"text":"[Powerful technique to test selectivity of agents acting on cardiac ion channels: the action potential voltage-clamp.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14660663","offsetInEndSection":75,"text":"[Molecular determinants of Na+\/Ca2+ exchange (NCX1) inhibition by SEA0400.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15231867","offsetInEndSection":71,"text":"[-5-ethoxyaniline] assessed on the cardiac Na+-Ca2+ exchanger, NCX1.1.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12491791","offsetInEndSection":96,"text":"[[Functional analysis of Na+\/Ca2+ exchanger using novel drugs and genetically engineered mice].]","beginSection":"title"}],"id":"5506c3e38e1671127b00000a","body":"The small molecule SEA0400 is an inhibitor of which ion antiporter\/exchanger","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14552856","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19850943","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16403454","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17109079","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23271792","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15829720","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25187324","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14717697","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12820654","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15531529"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12820654","offsetInEndSection":98,"text":"[PKA phosphorylation of the small heat-shock protein Hsp20 enhances its cardioprotective effects.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14717697","offsetInEndSection":66,"text":"[Some properties of human small heat shock protein Hsp20 (HspB6).]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15531529","offsetInEndSection":83,"text":"[Acetylation of heat shock protein 20 (Hsp20) regulates human myometrial activity.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16403454","offsetInEndSection":143,"text":"[The intertidal copepod Tigriopus japonicus small heat shock protein 20 gene (Hsp20) enhances thermotolerance of transformed Escherichia coli.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17109079","offsetInEndSection":69,"text":"[Small heat shock protein Hsp20 (HspB6) as a partner of 14-3-3gamma.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15829720","offsetInEndSection":130,"text":"[Transduction of phosphorylated heat shock-related protein 20, HSP20, prevents vasospasm of human umbilical artery smooth muscle.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14552856","offsetInEndSection":81,"text":"[Haemonchus contortus: molecular characterisation of a small heat shock protein.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25187324","offsetInEndSection":106,"text":"[Decreased expression of heat shock protein 20 in colorectal cancer and its implication in tumorigenesis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19850943","offsetInEndSection":118,"text":"[Identification of a protein phosphatase-1\/phospholamban complex that is regulated by cAMP-dependent phosphorylation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23271792","offsetInEndSection":97,"text":"[Phospholamban interactome in cardiac contractility and survival: A new vision of an old friend.]","beginSection":"title"}],"id":"5506ce078e1671127b00000b","body":"Which protein phosphatase has been found to interact with the heat shock protein, HSP20","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9751044","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25078119","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19201823","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11590213","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10935625","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26263168","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10644043","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10753909","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12086926","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21496385"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9751044","offsetInEndSection":59,"text":"[IKAP is a scaffold protein of the IkappaB kinase complex.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21496385","offsetInEndSection":148,"text":"[Effect of inhibition of the ubiquitin-proteasome-system and IκB kinase on airway inflammation and hyperresponsiveness in a murine model of asthma.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10935625","offsetInEndSection":90,"text":"[NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10753909","offsetInEndSection":137,"text":"[Role of NF-kappaB-dependent caveolin-1 expression in the mechanism of increased endothelial permeability induced by lipopolysaccharide.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12086926","offsetInEndSection":133,"text":"[Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10644043","offsetInEndSection":207,"text":"[Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3'-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11590213","offsetInEndSection":99,"text":"[Hepatocyte-specific IKK-β activation enhances VLDL-triglyceride production in APOE*3-Leiden mice.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19201823","offsetInEndSection":129,"text":"[Thalidomide inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production via down-regulation of MyD88 expression.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26263168","offsetInEndSection":96,"text":"[Kaempferol alleviates insulin resistance via hepatic IKK\/NF-κB signal in type 2 diabetic rats.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25078119","offsetInEndSection":120,"text":"[Carotenoid derivatives inhibit nuclear factor kappa B activity in bone and cancer cells by targeting key thiol groups.]","beginSection":"title"}],"id":"5506e2ff8e1671127b00000d","body":"Which are the subunits of the IkB protein kinase (IKK)","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17303919","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12387745","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2154753","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12603426","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17595324","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15536066","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12438279","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16460276","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19079347","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18775672"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15536066","offsetInEndSection":156,"text":"[Role for protein kinase Ctheta (PKCtheta) in TCR\/CD28-mediated signaling through the canonical but not the non-canonical pathway for NF-kappaB activation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16460276","offsetInEndSection":128,"text":"[Interleukin-1beta up-regulates RGS4 through the canonical IKK2\/IkappaBalpha\/NF-kappaB pathway in rabbit colonic smooth muscle.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12603426","offsetInEndSection":119,"text":"[Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17303919","offsetInEndSection":35,"text":"[The NF-kappaB regulatory network.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19079347","offsetInEndSection":114,"text":"[ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12438279","offsetInEndSection":135,"text":"[Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2154753","offsetInEndSection":136,"text":"[Peroxynitrite is a potent inhibitor of NF-{kappa}B activation triggered by inflammatory stimuli in cardiac and endothelial cell lines.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17595324","offsetInEndSection":169,"text":"[Involvement of a novel Rac\/RhoA guanosine triphosphatase-nuclear factor-kappaB inducing kinase signaling pathway mediating angiotensin II-induced RelA transactivation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12387745","offsetInEndSection":154,"text":"[Interferon induces NF-kappa B-inducing kinase\/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18775672","offsetInEndSection":54,"text":"[New insights into NF-kappaB regulation and function.]","beginSection":"title"}],"id":"5506eca18e1671127b00000f","body":"Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15920024","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25480325","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15851156","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11343972","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20226167","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16843546","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17578347","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17607353","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17052226","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15451514"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17052226","offsetInEndSection":89,"text":"[Role of ryanodine receptor mutations in cardiac pathology: more questions than answers?]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20226167","offsetInEndSection":128,"text":"[Arrhythmogenic Calmodulin Mutations Affect the Activation and Termination of Cardiac Ryanodine Receptor-mediated Ca2+ Release.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16843546","offsetInEndSection":79,"text":"[Human cardiac ryanodine receptor mutations in ion channel disorders in Japan.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11343972","offsetInEndSection":143,"text":"[Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15920024","offsetInEndSection":148,"text":"[Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25480325","offsetInEndSection":66,"text":"[Arrhythmogenic mechanisms in ryanodine receptor channelopathies.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15851156","offsetInEndSection":99,"text":"[Leaky Ca2+ release channel\/ryanodine receptor 2 causes seizures and sudden cardiac death in mice.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17607353","offsetInEndSection":159,"text":"[Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15451514","offsetInEndSection":62,"text":"[Regulation of ryanodine receptors by FK506 binding proteins.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17578347","offsetInEndSection":100,"text":"[Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia.]","beginSection":"title"}],"id":"550712739d0faaa527000008","body":"Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10873786","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/233137","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2664780","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18211921","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8022260","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12035062","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8178490","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7642612","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6292236","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7650000"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2664780","offsetInEndSection":105,"text":"[High-affinity binding of Escherichia coli SecB to the signal sequence region of a presecretory protein.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12035062","offsetInEndSection":106,"text":"[Effect of Downstream Sequence on the Cleavage of Envelop Protein 1 Signal Sequence in Hepatitis C Virus.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7642612","offsetInEndSection":101,"text":"[Expression of a functionally active human renal sodium-calcium exchanger lacking a signal sequence.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8178490","offsetInEndSection":203,"text":"[The signal-anchor domain of adenovirus E3-6.7K, a type III integral membrane protein, can direct adenovirus E3-gp19K, a type I integral membrane protein, into the membrane of the endoplasmic reticulum.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6292236","offsetInEndSection":116,"text":"[The signal sequence interacts with the methionine-rich domain of the 54-kD protein of signal recognition particle.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10873786","offsetInEndSection":105,"text":"[The HIV-1 Env protein signal sequence retards its cleavage and down-regulates the glycoprotein folding.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18211921","offsetInEndSection":164,"text":"[Cleavage of the ER-targeting signal sequence of parathyroid hormone-related protein is cell-type-specific and regulated in Cis by its nuclear localization signal.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/233137","offsetInEndSection":164,"text":"[The quaternary structure, antigenicity, and aggregational behavior of the secretory core protein of human hepatitis B virus are determined by its signal sequence.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8022260","offsetInEndSection":126,"text":"[Reversible topology of a bifunctional transmembrane protein depends upon the charge balance around its transmembrane domain.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7650000","offsetInEndSection":86,"text":"[Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin.]","beginSection":"title"}],"id":"550718e9fd1abe1741000001","body":"Where in a protein can a signal sequence be found","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19907056","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11989820","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16508312","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15994335","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10423016","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19047145","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12213228","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8313469","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16508311","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9202123"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16508312","offsetInEndSection":75,"text":"[The enigma of the numb-Notch relationship during mammalian embryogenesis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15994335","offsetInEndSection":134,"text":"[Stress-induced switch in Numb isoforms enhances Notch-dependent expression of subtype-specific transient receptor potential channel.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19047145","offsetInEndSection":122,"text":"[Opposite effects of Notch-1 and Notch-2 on mesothelioma cell survival under hypoxia are exerted through the Akt pathway.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9202123","offsetInEndSection":101,"text":"[Regulation of EGFR and Notch signaling by distinct isoforms of D-cbl during Drosophila development.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11989820","offsetInEndSection":54,"text":"[Multiple levels of Notch signal regulation (review).]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10423016","offsetInEndSection":53,"text":"[Localization of ADAM10 and Notch receptors in bone.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16508311","offsetInEndSection":133,"text":"[Distinct functions of human numb isoforms revealed by misexpression in the neural stem cell lineage in the Drosophila larval brain.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19907056","offsetInEndSection":134,"text":"[Mammalian Notch is modified by D-Xyl-alpha1-3-D-Xyl-alpha1-3-D-Glc-beta1-O-Ser: implementation of a method to study O-glucosylation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8313469","offsetInEndSection":98,"text":"[Distinct human NUMB isoforms regulate differentiation vs. proliferation in the neuronal lineage.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12213228","offsetInEndSection":103,"text":"[Notch-inducible hyperphosphorylated CREB and its ultradian oscillation in long-term memory formation.]","beginSection":"title"}],"id":"55072c803b8a5dc045000001","body":"Which are the different isoforms of the mammalian Notch receptor","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9454719","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8755245","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4018033","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3029758","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9224719","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10395561","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1973075","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19032167","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25266719","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4519026"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8755245","offsetInEndSection":66,"text":"[Patterns of variant polyadenylation signal usage in human genes.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1973075","offsetInEndSection":111,"text":"[Cleavage and polyadenylation factor CPF specifically interacts with the pre-mRNA 3' processing signal AAUAAA.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3029758","offsetInEndSection":60,"text":"[A composite polyadenylation signal with TATA box function.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9454719","offsetInEndSection":132,"text":"[Mutation of polyadenylation signals generates murine retroviruses that produce fused virus-cell RNA transcripts at high frequency.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19032167","offsetInEndSection":139,"text":"[Identification and characterization of polyadenylation signal (PAS) variants in human genomic sequences based on modified EST clustering.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4519026","offsetInEndSection":116,"text":"[Features of the chicken c-myc gene that influence the structure of c-myc RNA in normal cells and bursal lymphomas.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9224719","offsetInEndSection":102,"text":"[Human Fip1 is a subunit of CPSF that binds to U-rich RNA elements and stimulates poly(A) polymerase.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4018033","offsetInEndSection":94,"text":"[Hierarchy of polyadenylation site usage by bovine papillomavirus in transformed mouse cells.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25266719","offsetInEndSection":153,"text":"[A Potential New Mechanism of Arsenic Carcinogenesis: Depletion of Stem-Loop Binding Protein and Increase in Polyadenylated Canonical Histone H3.1 mRNA.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10395561","offsetInEndSection":86,"text":"[Polyadenylation in rice tungro bacilliform virus: cis-acting signals and regulation.]","beginSection":"title"}],"id":"550739cf3b8a5dc045000002","body":"Which is the RNA sequence of the canonical polyadenylation signal","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17110441","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24189369","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25714420","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21204804","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22596016","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25914188","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19557857","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27864847","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23409955","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21364700"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17110441","offsetInEndSection":77,"text":"[Intellectual disability without epilepsy associated with STXBP1 disruption.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24189369","offsetInEndSection":109,"text":"[Early epileptic encephalopathies associated with STXBP1 mutations: Could we better delineate the phenotype?]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19557857","offsetInEndSection":75,"text":"[De novo STXBP1 mutations in mental retardation and nonsyndromic epilepsy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25714420","offsetInEndSection":82,"text":"[A de-novo STXBP1 gene mutation in a patient showing the Rett syndrome phenotype.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25914188","offsetInEndSection":101,"text":"[Mutations in epilepsy and intellectual disability genes in patients with features of Rett syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23409955","offsetInEndSection":152,"text":"[Reduction of seizure frequency after epilepsy surgery in a patient with STXBP1 encephalopathy and clinical description of six novel mutation carriers.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21364700","offsetInEndSection":126,"text":"[Epilepsy, Behavioral Abnormalities, and Physiological Comorbidities in Syntaxin-Binding Protein 1 (STXBP1) Mutant Zebrafish.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27864847","offsetInEndSection":145,"text":"[Diagnostic Targeted Resequencing in 349 Patients with Drug-Resistant Pediatric Epilepsies Identifies Causative Mutations in 30 Different Genes.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22596016","offsetInEndSection":68,"text":"[A novel STXBP1 mutation causes focal seizures with neonatal onset.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21204804","offsetInEndSection":108,"text":"[STXBP1 mutations cause not only Ohtahara syndrome but also West syndrome--result of Japanese cohort study.]","beginSection":"title"}],"id":"550748a3bde8548216000001","body":"Are mutations in the STXBP1 gene associated with epilepsy","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24278531","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20819124","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27212245","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27395339","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24607896","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15548370","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27397693","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27044866","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11181412","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25984514"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27212245","offsetInEndSection":75,"text":"[Role of epithelial to mesenchymal transition in hepatocellular carcinoma.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24278531","offsetInEndSection":54,"text":"[Epithelial-mesenchymal Transition and Cell Invasion.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27397693","offsetInEndSection":89,"text":"[Basement membrane fragments in the context of the epithelial-to-mesenchymal transition.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27044866","offsetInEndSection":167,"text":"[Determination of a Comprehensive Alternative Splicing Regulatory Network and Combinatorial Regulation by Key Factors during the Epithelial-to-Mesenchymal Transition.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24607896","offsetInEndSection":100,"text":"[Overexpression of Snail in retinal pigment epithelial triggered epithelial-mesenchymal transition.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27395339","offsetInEndSection":115,"text":"[Cold-inducible RNA-binding protein promotes epithelial-mesenchymal transition by activating ERK and p38 pathways.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25984514","offsetInEndSection":121,"text":"[Epithelial-mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: An update.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20819124","offsetInEndSection":147,"text":"[EGF\/TGFβ1 co-stimulation of oral squamous cell carcinoma cells causes an epithelial-mesenchymal transition cell phenotype expressing laminin 332.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11181412","offsetInEndSection":183,"text":"[Fuzheng Huayu Recipe Ameliorates Liver Fibrosis by Restoring Balance between Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Hepatic Stellate Cells.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15548370","offsetInEndSection":135,"text":"[Redox processes inform multivariate transdifferentiation trajectories associated with TGFβ-induced epithelial-mesenchymal transition.]","beginSection":"title"}],"id":"55074fa8bde8548216000003","body":"What is the definition and the biological role of epithelial-mesenchymal transition (EMT)","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27479206","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27837895","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6180691","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17655675","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2466399","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21332065","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7002302","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10653680","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12365869","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19227418"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27479206","offsetInEndSection":60,"text":"[Bidirectional ventricular tachycardia of unusual etiology.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6180691","offsetInEndSection":74,"text":"[[Bidirectional ventricular tachycardia (arguments in favor of reentry)].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21332065","offsetInEndSection":170,"text":"[[Catecholaminergic ventricular tachycardia initially diagnosed as right ventricular outflow tract arrhythmia. Differential diagnosis of CPVT, LQTS and RVOT arrhythmia].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27837895","offsetInEndSection":96,"text":"[Bidirectional Ventricular Tachycardia Due to a Mixture of Focal Fascicular Firing and Reentry.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10653680","offsetInEndSection":69,"text":"[Ventricular tachycardia in the absence of structural heart disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12365869","offsetInEndSection":138,"text":"[Exercise-induced bidirectional ventricular tachycardia with alternating right and left bundle branch block-type patterns--a case report.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2466399","offsetInEndSection":132,"text":"[Reproducibility of exercise-induced ventricular arrhythmia in patients undergoing evaluation for malignant ventricular arrhythmia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7002302","offsetInEndSection":108,"text":"[Effects of lignocaine on bidirectional tachycardia and on digitalis-induced atrial tachycardia with block.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17655675","offsetInEndSection":137,"text":"[Flecainide suppresses bidirectional ventricular tachycardia and reverses tachycardia-induced cardiomyopathy in Andersen-Tawil syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19227418","offsetInEndSection":112,"text":"[The incidence and risk factors of arrhythmias in the early period after cardiac surgery in pediatric patients.]","beginSection":"title"}],"id":"5507ea9a0195c16935000008","body":"What type of arrhythmia is known as bidirectional ventricular tachycardia (BDVT)","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15082315","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16443603","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15684388","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20696248","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19088254","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15232583","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16799550","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25142088","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15728840","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16142228"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19088254","offsetInEndSection":129,"text":"[Lysine 48-linked polyubiquitination of organic anion transporter-1 is essential for its protein kinase C-regulated endocytosis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15232583","offsetInEndSection":112,"text":"[Proteolysis-independent regulation of the transcription factor Met4 by a single Lys 48-linked ubiquitin chain.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15684388","offsetInEndSection":221,"text":"[F-box only protein 31 (FBXO31) negatively regulates p38 mitogen-activated protein kinase (MAPK) signaling by mediating lysine 48-linked ubiquitination and degradation of mitogen-activated protein kinase kinase 6 (MKK6).]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20696248","offsetInEndSection":50,"text":"[K63-linked ubiquitination and neurodegeneration.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16443603","offsetInEndSection":170,"text":"[Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-Tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25142088","offsetInEndSection":144,"text":"[UBC13, an E2 enzyme for Lys63-linked ubiquitination, functions in root development by affecting auxin signaling and Aux\/IAA protein stability.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16142228","offsetInEndSection":189,"text":"[HIV replication in CD4+ T lymphocytes in the presence and absence of follicular dendritic cells: inhibition of replication mediated by α-1-antitrypsin through altered IκBα ubiquitination.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15728840","offsetInEndSection":124,"text":"[Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15082315","offsetInEndSection":182,"text":"[Activated inositol 1,4,5-trisphosphate receptors are modified by homogeneous Lys-48- and Lys-63-linked ubiquitin chains, but only Lys-48-linked chains are required for degradation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16799550","offsetInEndSection":91,"text":"[Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology.]","beginSection":"title"}],"id":"5507fc114b2a315d41000003","body":"What is the biological role of K-48 linked protein ubiquitination","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24072410","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21900893","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9476544","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10821756","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9250685","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19962989","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25270119","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16902596","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20965565","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17566775"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9476544","offsetInEndSection":101,"text":"[Role of inositol 1,4,5-trisphosphate receptors in regulating apoptotic signaling and heart failure.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16902596","offsetInEndSection":104,"text":"[Regulation of the sarcoplasmic reticulum Ca2+-ATPase expression in the hypertrophic and failing heart.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24072410","offsetInEndSection":114,"text":"[SERCA2 Haploinsufficiency in a Mouse Model of Darier Disease Causes a Selective Predisposition to Heart Failure.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19962989","offsetInEndSection":141,"text":"[Multiple and diverse coexpression, location, and regulation of additional SERCA2 and SERCA3 isoforms in nonfailing and failing human heart.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21900893","offsetInEndSection":87,"text":"[SERCA2a: a prime target for modulation of cardiac contractility during heart failure.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10821756","offsetInEndSection":99,"text":"[Calcium extrusion is critical for cardiac morphogenesis and rhythm in embryonic zebrafish hearts.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20965565","offsetInEndSection":117,"text":"[Cardiomyocyte-specific disruption of Serca2 in adult mice causes sarco(endo)plasmic reticulum stress and apoptosis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17566775","offsetInEndSection":103,"text":"[Elevated Ca2+ ATPase (SERCA2) activity in tuna hearts: comparative aspects of temperature dependence.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9250685","offsetInEndSection":52,"text":"[Cardiac hypertrophy and thyroid hormone signaling.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25270119","offsetInEndSection":51,"text":"[Regulation of SERCA pumps expression in diabetes.]","beginSection":"title"}],"id":"5508453a4b2a315d41000008","body":"What is the biological role of SERCA2 SUMOylation in cardiac physiology and pathophysiology, such as in heart failure","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20498386","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25589200","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26336591","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23129602","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12510039","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26477040","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26738270","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23980911","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24918648","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25687206"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26738270","offsetInEndSection":76,"text":"[[Vedolizumab (Entyvio®) for the treatment of inflammatory bowel diseases].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24918648","offsetInEndSection":62,"text":"[Vedolizumab for the treatment of inflammatory bowel disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23980911","offsetInEndSection":105,"text":"[Vedolizumab for the treatment of IBD: a selective therapeutic approach targeting pathogenic a4b7 cells.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26477040","offsetInEndSection":168,"text":"[Vedolizumab for the Treatment of Adults with Moderate-to-Severe Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23129602","offsetInEndSection":44,"text":"[Which are the antibodies to watch in 2013?]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25687206","offsetInEndSection":67,"text":"[Introducing vedolizumab to clinical practice: who, when, and how?]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26336591","offsetInEndSection":86,"text":"[Vedolizumab: an α4β7 integrin antagonist for ulcerative colitis and Crohn's disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25589200","offsetInEndSection":126,"text":"[Vedolizumab: a review of its use in adult patients with moderately to severely active ulcerative colitis or Crohn's disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20498386","offsetInEndSection":47,"text":"[Antibody-based therapeutics to watch in 2011.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12510039","offsetInEndSection":117,"text":"[Efficacy and safety of antiintegrin antibody for inflammatory bowel disease: a systematic review and meta-analysis.]","beginSection":"title"}],"id":"5508685b4b2a315d4100000a","body":"List the diseases that can be treated using Vedolizumab.","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18033688","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17671148","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20514015","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15011787","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18394559","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19433372","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18201769","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16336750","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22832803","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15059649"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17671148","offsetInEndSection":128,"text":"[Antibodies to the epidermal growth factor receptor in non small cell lung cancer: current status of matuzumab and panitumumab.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15011787","offsetInEndSection":47,"text":"[Technology evaluation: Matuzumab, Merck KGaA.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22832803","offsetInEndSection":147,"text":"[A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancer.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15059649","offsetInEndSection":141,"text":"[Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18394559","offsetInEndSection":60,"text":"[A molecular view of anti-ErbB monoclonal antibody therapy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19433372","offsetInEndSection":64,"text":"[[Targeting HER pathway in head and neck and thoracic cancers].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20514015","offsetInEndSection":128,"text":"[Peptide mimotopes recognized by antibodies cetuximab and matuzumab induce a functionally equivalent anti-EGFR immune response.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18033688","offsetInEndSection":127,"text":"[Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18201769","offsetInEndSection":87,"text":"[ErbB-directed immunotherapy: antibodies in current practice and promising new agents.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16336750","offsetInEndSection":99,"text":"[Recent data with anti-epidermal growth factor receptor antibodies and irinotecan in colon cancer.]","beginSection":"title"}],"id":"55086ea1098a1b487b000001","body":"Matuzumab has been tested for treatment of which cancers","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19504542","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10404161","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21136756","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25315852","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6137005","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22059388","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11717465","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15665377","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11586298","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21526838"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25315852","offsetInEndSection":95,"text":"[Advances in Phos-tag-based methodologies for separation and detection of the phosphoproteome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21136756","offsetInEndSection":87,"text":"[Phosphoproteomics for the discovery of kinases as cancer biomarkers and drug targets.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15665377","offsetInEndSection":82,"text":"[Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22059388","offsetInEndSection":168,"text":"[Improvement of phosphoproteome analyses using FAIMS and decision tree fragmentation. application to the insulin signaling pathway in Drosophila melanogaster S2 cells.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11717465","offsetInEndSection":126,"text":"[Quantitative phosphoproteomics of vasopressin-sensitive renal cells: regulation of aquaporin-2 phosphorylation at two sites.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6137005","offsetInEndSection":172,"text":"[Facile identification and quantitation of protein phosphorylation via beta-elimination and Michael addition with natural abundance and stable isotope labeled thiocholine.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11586298","offsetInEndSection":177,"text":"[Quantitative phosphoproteome analysis of lysophosphatidic acid induced chemotaxis applying dual-step (18)O labeling coupled with immobilized metal-ion affinity chromatography.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19504542","offsetInEndSection":65,"text":"[Phosphopeptide fragmentation and analysis by mass spectrometry.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10404161","offsetInEndSection":77,"text":"[High mass accuracy phosphopeptide identification using tandem mass spectra.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21526838","offsetInEndSection":101,"text":"[Pinpointing phosphorylation sites: Quantitative filtering and a novel site-specific x-ion fragment.]","beginSection":"title"}],"id":"550889db098a1b487b000005","body":"What is the advantage of neutral loss detection in phosphoproteomics","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9529131","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11976329","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7937954","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17693123","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10837071","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9596659","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19302050","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11726516","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16953224","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10671572"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19302050","offsetInEndSection":82,"text":"[Regulation and function of NF-kappaB transcription factors in the immune system.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7937954","offsetInEndSection":142,"text":"[Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11726516","offsetInEndSection":72,"text":"[Activation of noncanonical NF-kappaB signaling by the oncoprotein Tio.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9596659","offsetInEndSection":72,"text":"[NF-kappaB transcription factors are involved in normal erythropoiesis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10837071","offsetInEndSection":58,"text":"[Rescue of TRAF3-null mice by p100 NF-kappa B deficiency.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10671572","offsetInEndSection":160,"text":"[Essential role of human leukocyte antigen-encoded proteasome subunits in NF-kappaB activation and prevention of tumor necrosis factor-alpha-induced apoptosis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11976329","offsetInEndSection":64,"text":"[Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9529131","offsetInEndSection":113,"text":"[Regulation of p100 (NFKB2) expression in human monocytes in response to inflammatory mediators and lymphokines.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16953224","offsetInEndSection":167,"text":"[Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17693123","offsetInEndSection":50,"text":"[Nuclear factor-kappaB1: regulation and function.]","beginSection":"title"}],"id":"55088e412e93f0133a000001","body":"Is p100 the precursor protein molecule of the NF-kappaB transcription factor subunit p50","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24352158","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16501490","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2019749","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19375957","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26072307","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15326289","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15326289","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26139298","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16531988","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26277791"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15326289","offsetInEndSection":96,"text":"[In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19375957","offsetInEndSection":71,"text":"[A translational study of urine miRNAs in acute myocardial infarction.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15326289","offsetInEndSection":102,"text":"[Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT).]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24352158","offsetInEndSection":98,"text":"[Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26139298","offsetInEndSection":101,"text":"[Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26072307","offsetInEndSection":133,"text":"[Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26277791","offsetInEndSection":189,"text":"[Targeted Stage-Specific Inflammatory microRNA Profiling in Urine During Disease Progression in Experimental Autoimmune Encephalomyelitis: Markers of Disease Progression and Drug Response.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2019749","offsetInEndSection":105,"text":"[Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16501490","offsetInEndSection":99,"text":"[Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16531988","offsetInEndSection":86,"text":"[Urinary exosomal transcription factors, a new class of biomarkers for renal disease.]","beginSection":"title"}],"id":"550895c12e93f0133a000002","body":"Can exosomes be detected in urine","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16213628","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15082315","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15728840","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15684388","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12198498","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10888878","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12794086","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22890725","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14633995","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18042044"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16213628","offsetInEndSection":143,"text":"[Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson's and other conformational diseases?]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10888878","offsetInEndSection":94,"text":"[Proteasome inhibition promotes Parkin-Ubc13 interaction and lysine 63-linked ubiquitination.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15684388","offsetInEndSection":221,"text":"[F-box only protein 31 (FBXO31) negatively regulates p38 mitogen-activated protein kinase (MAPK) signaling by mediating lysine 48-linked ubiquitination and degradation of mitogen-activated protein kinase kinase 6 (MKK6).]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15082315","offsetInEndSection":182,"text":"[Activated inositol 1,4,5-trisphosphate receptors are modified by homogeneous Lys-48- and Lys-63-linked ubiquitin chains, but only Lys-48-linked chains are required for degradation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22890725","offsetInEndSection":104,"text":"[Nonspecific yet decisive: Ubiquitination can affect the native-state dynamics of the modified protein.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15728840","offsetInEndSection":124,"text":"[Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12198498","offsetInEndSection":94,"text":"[Lysine 63-linked polyubiquitin chain may serve as a targeting signal for the 26S proteasome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14633995","offsetInEndSection":110,"text":"[Ubiquitin- and MDM2 E3 ligase-independent proteasomal turnover of nucleostemin in response to GTP depletion.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12794086","offsetInEndSection":90,"text":"[Differential ubiquitination defines the functional status of the tumor suppressor Smad4.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18042044","offsetInEndSection":177,"text":"[Two different classes of E2 ubiquitin-conjugating enzymes are required for the mono-ubiquitination of proteins and elongation by polyubiquitin chains with a specific topology.]","beginSection":"title"}],"id":"550899c92e93f0133a000003","body":"Is K-63 linked protein ubiquitination related to proteasomal degradation","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18219926","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25940165","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25621782","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25926077","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14726714","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21825009","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18235442","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15022111","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18443532","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21719393"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18235442","offsetInEndSection":108,"text":"[Drug Insight: gastrointestinal stromal tumors (GIST)--the solid tumor model for cancer-specific treatment.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14726714","offsetInEndSection":99,"text":"[Recent advances in cell biology, diagnosis, and therapy of gastrointestinal stromal tumor (GIST).]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18219926","offsetInEndSection":132,"text":"[[Successful treatment of huge peritoneal metastasis from duodenal gastrointestinal stromal tumor resistant for imatinib mesylate].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25621782","offsetInEndSection":142,"text":"[[Gastrointestinal stromal tumors: a rare nosological entity and a model example for the use of personalized therapy with a molecular basis].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25940165","offsetInEndSection":82,"text":"[[Surgical principles of gastrointestinal stromal tumors at different locations].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25926077","offsetInEndSection":131,"text":"[Therapeutic Efficacy Assessment of CK6, a Monoclonal KIT Antibody, in a Panel of Gastrointestinal Stromal Tumor Xenograft Models.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21825009","offsetInEndSection":173,"text":"[The heat shock protein 90 inhibitor IPI-504 induces KIT degradation, tumor shrinkage, and cell proliferation arrest in xenograft models of gastrointestinal stromal tumors.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18443532","offsetInEndSection":99,"text":"[[Gastrointestinal stromal tumors (GIST) - clinical experience and current therapeutical aspects].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21719393","offsetInEndSection":106,"text":"[Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15022111","offsetInEndSection":125,"text":"[[Gastrointestinal stromal tumors: a broad clinical spectrum from incidental -discovery to acute gastrointestinal bleeding].]","beginSection":"title"}],"id":"5509b6d22e93f0133a000005","body":"What are the treatments of choice for GIST (gastrointestinal stromal tumor)","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11030075","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11822862","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15605526","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10796047","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20206110","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10202797","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27468353","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12449725","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23797121","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11241410"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10796047","offsetInEndSection":109,"text":"[Helicobacter pylori in the upper gastrointestinal tract: medical or surgical treatment of gastric lymphoma?]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20206110","offsetInEndSection":77,"text":"[Long-term follow-up of gastric lymphoma after stomach conserving treatment.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15605526","offsetInEndSection":51,"text":"[[Bleeding gastric lymphoma: report of two cases].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11822862","offsetInEndSection":73,"text":"[Laparoscopy-assisted distal gastrectomy for gastric malignant lymphoma.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11030075","offsetInEndSection":110,"text":"[Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11241410","offsetInEndSection":143,"text":"[Histological and immunological parameters to predict treatment outcome of Helicobacter pylori eradication in low-grade gastric MALT lymphoma.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12449725","offsetInEndSection":155,"text":"[Differentiation of low-grade gastric MALT lymphoma and high-grade gastric MALT lymphoma: the clinical value of Ga-67 citrate scintigraphy--a pilot study.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27468353","offsetInEndSection":133,"text":"[Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori infection: a review of current diagnosis and management.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10202797","offsetInEndSection":20,"text":"[Gastric neoplasia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23797121","offsetInEndSection":32,"text":"[MALT lymphoma: forget surgery?]","beginSection":"title"}],"id":"5509ba931180f13250000001","body":"What is the treatment of choice  for gastric lymphoma","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11472312","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11842954","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11812943","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15542584","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26351412","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21637044","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14056869","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17848697","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16843733","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11812943"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11472312","offsetInEndSection":114,"text":"[Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15542584","offsetInEndSection":106,"text":"[Ileal mucosa-associated lymphoid tissue lymphoma presenting with small bowel obstruction: a case report.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14056869","offsetInEndSection":113,"text":"[Lymphoma-associated ulcerative bowel disease in the hamster (Mesocricetus auratus) induced by an unusual agent.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11842954","offsetInEndSection":41,"text":"[Primary malignant large bowel lymphoma.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16843733","offsetInEndSection":100,"text":"[Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21637044","offsetInEndSection":134,"text":"[Primary peripheral T-cell lymphoma of the colon mimics inflammatory bowel disease: a potential pitfall with F-18 FDG PET\/CT imaging.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17848697","offsetInEndSection":94,"text":"[Primary gastrointestinal lymphoma: spectrum of imaging findings with pathologic correlation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11812943","offsetInEndSection":105,"text":"[Primary follicular lymphoma of the gastrointestinal tract: a clinical and pathologic study of 26 cases.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11812943","offsetInEndSection":81,"text":"[Gastrointestinal lymphomas: Morphology, immunophenotype and molecular features.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26351412","offsetInEndSection":63,"text":"[T-Cell Lymphomas Presenting as Colon Ulcers and Eosinophilia.]","beginSection":"title"}],"id":"5509bd6a1180f13250000002","body":"What disease is small bowel lymphoma commonly associated with","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25098475","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20076651","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11619517","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26591053","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19234473","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2232068","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17459314","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15409751","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3609876","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16380396"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25098475","offsetInEndSection":29,"text":"[Hyperosmia in Lyme disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17459314","offsetInEndSection":41,"text":"[Methotrexate, hyperosmia, and migraine.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20076651","offsetInEndSection":61,"text":"[Genetic elucidation of human hyperosmia to isovaleric acid.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2232068","offsetInEndSection":63,"text":"[Hyperosmia and depression following exposure to toxic vapors.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15409751","offsetInEndSection":140,"text":"[[Hyperlectrolytemia (hypertension and hyperosmia of body fluids) with water deficit, electrolyte overload, renal and endocrine disorders].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19234473","offsetInEndSection":172,"text":"[Hyperosmia, ectrodactyly, mild intellectual disability, and other defects in a male patient with an X-linked partial microduplication and overexpression of the KAL1 gene.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11619517","offsetInEndSection":24,"text":"[A memoir of olfaction.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26591053","offsetInEndSection":87,"text":"[[PHYSIOLOGICAL APPROACH TO RESTORING OSMOTIC HOMEOSTASIS IN RATS WITH HYPERNATREMIA].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3609876","offsetInEndSection":41,"text":"[A role for anticonvulsants in migraine.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16380396","offsetInEndSection":105,"text":"[Olfactory sensitivity in medical laboratory workers occupationally exposed to organic solvent mixtures.]","beginSection":"title"}],"id":"5509c52f1180f13250000004","body":"What is hyperosmia","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21887533","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16142214","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8479171","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11346046","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1082331","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22387835","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22741132","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2305208","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19296138","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25096763"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16142214","offsetInEndSection":82,"text":"[Auditory abnormalities in autism: toward functional distinctions among findings.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25096763","offsetInEndSection":121,"text":"[Determinants of variations in self-reported barriers to colonoscopy among uninsured patients in a primary care setting.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21887533","offsetInEndSection":90,"text":"[Delayed presentation of splenic rupture following colonoscopy: clinical and CT findings.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1082331","offsetInEndSection":98,"text":"[The results of diagnostic colonoscopy in the management of unexplained bleeding from the rectum.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11346046","offsetInEndSection":95,"text":"[Evidence that the pattern of visuomotor sequence learning is altered in children with autism.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2305208","offsetInEndSection":29,"text":"[The benefit of colonoscopy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22741132","offsetInEndSection":65,"text":"[Korean guidelines for postpolypectomy colonoscopy surveillance.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8479171","offsetInEndSection":77,"text":"[Colonoscopy for intermittent rectal bleeding: impact on patient management.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19296138","offsetInEndSection":85,"text":"[Correlation of incidental colorectal wall thickening at CT compared to colonoscopy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22387835","offsetInEndSection":69,"text":"[[Korean guidelines for post-polypectomy colonoscopic surveillance].]","beginSection":"title"}],"id":"5509ce9ec2af5d5b70000001","body":"What colonoscopy findings have been reported in autism","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11825323","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20041841","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6373262","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27030392","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21626366","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18393876","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2417849","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10210515","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8417505","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9918445"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20041841","offsetInEndSection":54,"text":"[Amiodarone - a 'broad spectrum' antiarrhythmic drug.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6373262","offsetInEndSection":66,"text":"[Combined anti-arrhythmic therapy with class 1 and class 3 drugs.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27030392","offsetInEndSection":140,"text":"[The class III anti-arrhythmic agent, amiodarone, inhibits voltage-dependent K(+) channels in rabbit coronary arterial smooth muscle cells.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2417849","offsetInEndSection":69,"text":"[Delayed ventricular repolarization as an anti-arrhythmic principle.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10210515","offsetInEndSection":123,"text":"[Optimal management with Class I and Class III antiarrhythmic drugs should be done in the outpatient setting: protagonist.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11825323","offsetInEndSection":48,"text":"[Amiodarone -- waxed and waned and waxed again.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9918445","offsetInEndSection":80,"text":"[Intravenous amiodarone for ventricular arrhythmias: overview and clinical use.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8417505","offsetInEndSection":62,"text":"[Five-year follow-up of 589 patients treated with amiodarone.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21626366","offsetInEndSection":58,"text":"[Management of unstable arrhythmias in cardiogenic shock.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18393876","offsetInEndSection":124,"text":"[Pharmacological therapy in children with nodal reentry tachycardia: when, how and how long to treat the affected patients.]","beginSection":"title"}],"id":"5509df4ac2af5d5b70000003","body":"Is amiodarone a class I anti-arrhythmic drug","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12620240","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20702407","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12134165","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16064138","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23575811","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17095009","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9624167","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26237213","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15546616","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7838148"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9624167","offsetInEndSection":90,"text":"[Collapsin-1 covalently dimerizes, and dimerization is necessary for collapsing activity.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12620240","offsetInEndSection":66,"text":"[Insights into the regulatory mechanism for caspase-8 activation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20702407","offsetInEndSection":105,"text":"[Structural insights into the dimerization of the response regulator ComE from Streptococcus pneumoniae.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12134165","offsetInEndSection":116,"text":"[A conserved mechanism for Bni1- and mDia1-induced actin assembly and dual regulation of Bni1 by Bud6 and profilin.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16064138","offsetInEndSection":28,"text":"[Genome recognition by MYC.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23575811","offsetInEndSection":116,"text":"[Electric field gradient quadrupole Raman modes observed in plasmon-driven catalytic reactions revealed by HV-TERS.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17095009","offsetInEndSection":123,"text":"[Crystal structure of the bifunctional ATP sulfurylase-APS kinase from the chemolithotrophic thermophile Aquifex aeolicus.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26237213","offsetInEndSection":102,"text":"[Key Residues Regulating the Reductase Activity of the Human Mitochondrial Apoptosis Inducing Factor.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15546616","offsetInEndSection":102,"text":"[Structure and activity of the flagellar rotor protein FliY: a member of the CheC phosphatase family.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7838148","offsetInEndSection":118,"text":"[Analysis of a glucocorticoid-estrogen receptor chimera reveals that dimerization energetics are under ionic control.]","beginSection":"title"}],"id":"5509ec41c2af5d5b70000006","body":"Is HER2 active only when it dimerizes","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27119963","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21593866","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27219663","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19848406","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11507753","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24468393","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21144814","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26150950","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25929842","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22324799"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27219663","offsetInEndSection":136,"text":"[Sensitivity of mass spectrometry analysis depends on the shape of the filtration unit used for filter aided sample preparation (FASP).]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21144814","offsetInEndSection":128,"text":"[Comparison of ultrafiltration units for proteomic and N-glycoproteomic analysis by the filter-aided sample preparation method.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26150950","offsetInEndSection":135,"text":"[Thiol-free reducing agents in electrophoretic separations and FASP proteolytic digestions for the analysis of metal-binding proteins.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24468393","offsetInEndSection":127,"text":"[Combining TBP-based rOFFGEL-IEF with FASP and nLC-ESI-LTQ-MS\/MS for the analysis of cisplatin-binding proteins in rat kidney.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11507753","offsetInEndSection":113,"text":"[Enhanced FASP (eFASP) to increase proteome coverage and sample recovery for quantitative proteomic experiments.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19848406","offsetInEndSection":117,"text":"[Combination of FASP and StageTip-based fractionation allows in-depth analysis of the hippocampal membrane proteome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25929842","offsetInEndSection":155,"text":"[Protein identification and quantification from riverbank grape, Vitis riparia: Comparing SDS-PAGE and FASP-GPF techniques for shotgun proteomic analysis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27119963","offsetInEndSection":109,"text":"[Quantitative Evaluation of Filter Aided Sample Preparation (FASP) and Multienzyme Digestion FASP Protocols.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21593866","offsetInEndSection":128,"text":"[MStern Blotting-High Throughput Polyvinylidene Fluoride (PVDF) Membrane-Based Proteomic Sample Preparation for 96-Well Plates.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22324799","offsetInEndSection":116,"text":"[Consecutive proteolytic digestion in an enzyme reactor increases depth of proteomic and phosphoproteomic analysis.]","beginSection":"title"}],"id":"5509f433c2af5d5b70000008","body":"What is the method FASP used for","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27528754","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24552748","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24667321","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21729784","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6255902","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25828869","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11410670","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24846995","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25436590","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17499016"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24667321","offsetInEndSection":108,"text":"[Genetic variation in the non-coding genome: Involvement of micro-RNAs and long non-coding RNAs in disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24846995","offsetInEndSection":51,"text":"[[The emerging landscape of long non-coding RNAs].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25436590","offsetInEndSection":82,"text":"[Long antisense non-coding RNAs and the epigenetic regulation of gene expression.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25828869","offsetInEndSection":116,"text":"[Non-coding RNAs and hypertension-unveiling unexpected mechanisms of hypertension by the dark matter of the genome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6255902","offsetInEndSection":178,"text":"[Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjögren's syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27528754","offsetInEndSection":68,"text":"[Non-coding RNAs and disease: the classical ncRNAs make a comeback.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24552748","offsetInEndSection":205,"text":"[Insights into multiple sclerosis provided by non-coding RNAs: meeting summary from the symposium 'non-coding RNAs in autoimmune disorders of the central nervous system' on 5 April 2013 in Warsaw, Poland.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17499016","offsetInEndSection":110,"text":"[Complete sequence of the mitochondrial genome of Taenia saginata: comparison with T. solium and T. asiatica.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21729784","offsetInEndSection":84,"text":"[A novel molecular mechanism in human genetic disease: a DNA repeat-derived lncRNA.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11410670","offsetInEndSection":100,"text":"[RNA-seq based transcriptional map of bovine respiratory disease pathogen \"Histophilus somni 2336\".]","beginSection":"title"}],"id":"535d2cf09a4572de6f000004","body":"What is the number of long non coding RNAs in the human genome","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8201617","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1798333","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11739005","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17719121","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23640990","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27623443","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8065364","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18266558","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16463100","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23449093"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11739005","offsetInEndSection":82,"text":"[A comprehensive survey of non-canonical splice sites in the human transcriptome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8201617","offsetInEndSection":76,"text":"[Analysis of canonical and non-canonical splice sites in mammalian genomes.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1798333","offsetInEndSection":75,"text":"[SpliceDB: database of canonical and non-canonical mammalian splice sites.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23640990","offsetInEndSection":72,"text":"[Functional implications of splicing polymorphisms in the human genome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23449093","offsetInEndSection":113,"text":"[Novel bioinformatics method for identification of genome-wide non-canonical spliced regions using RNA-Seq data.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27623443","offsetInEndSection":129,"text":"[From Cryptic Toward Canonical Pre-mRNA Splicing in Pompe Disease: a Pipeline for the Development of Antisense Oligonucleotides.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17719121","offsetInEndSection":81,"text":"[Dual-specificity splice sites function alternatively as 5' and 3' splice sites.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16463100","offsetInEndSection":78,"text":"[Features of Arabidopsis genes and genome discovered using full-length cDNAs.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8065364","offsetInEndSection":97,"text":"[Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18266558","offsetInEndSection":126,"text":"[Extent and diversity of human alternative splicing established by complementary database annotation and microarray analysis.]","beginSection":"title"}],"id":"535d35779a4572de6f000005","body":"What is the proportion of non canonical splice sites in the human genome","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11504710","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17526652","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11741309","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12480542","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19567751","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15191886","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15863505","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16600288","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11504710","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22040806"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11504710","offsetInEndSection":112,"text":"[Interaction of HRC (histidine-rich Ca(2+)-binding protein) and triadin in the lumen of sarcoplasmic reticulum.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17526652","offsetInEndSection":84,"text":"[Histidine-rich Ca-binding protein interacts with sarcoplasmic reticulum Ca-ATPase.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11741309","offsetInEndSection":110,"text":"[Ca(2+)-dependent interaction of triadin with histidine-rich Ca(2+)-binding protein carboxyl-terminal region.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12480542","offsetInEndSection":127,"text":"[Increased Ca2+ storage capacity in the sarcoplasmic reticulum by overexpression of HRC (histidine-rich Ca2+ binding protein).]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15863505","offsetInEndSection":102,"text":"[Histidine-rich calcium binding protein: the new regulator of sarcoplasmic reticulum calcium cycling.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19567751","offsetInEndSection":109,"text":"[Junctin and the histidine-rich Ca2+ binding protein: potential roles in heart failure and arrhythmogenesis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16600288","offsetInEndSection":118,"text":"[Histidine-rich Ca binding protein: a regulator of sarcoplasmic reticulum calcium sequestration and cardiac function.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15191886","offsetInEndSection":79,"text":"[Regulation of myocardial function by histidine-rich, calcium-binding protein.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22040806","offsetInEndSection":92,"text":"[Overexpression of histidine-rich calcium binding protein in equine ventricular myocardium.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11504710","offsetInEndSection":134,"text":"[Characterization of Ca(2+)-Dependent Protein-Protein Interactions within the Ca(2+) Release Units of Cardiac Sarcoplasmic Reticulum.]","beginSection":"title"}],"id":"54c12fd1f693c3b16b000001","body":"Does the histidine-rich Ca-binding protein (HRC) interact with triadin","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11152014","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21673672","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7875632","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10810787","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9918445","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15725495","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1290288","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1712704","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12109286","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/658142"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1290288","offsetInEndSection":87,"text":"[[Principles for the classification of anti-arrhythmia agents in cardiac arrhythmias].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10810787","offsetInEndSection":53,"text":"[[Current classification of anti-arrhythmia agents].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7875632","offsetInEndSection":65,"text":"[Classification and mechanism of action of antiarrhythmic drugs.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12109286","offsetInEndSection":136,"text":"[[Comparative study of the anti-arrhythmic activity of cardiocyclide and nibentan in hypersympathotonia and acute myocardial ischemia].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21673672","offsetInEndSection":85,"text":"[Molecular basis for class Ib anti-arrhythmic inhibition of cardiac sodium channels.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15725495","offsetInEndSection":121,"text":"[Synthesis, structure-activity relationship of some new anti-arrhythmic 5-arylidene imidazolidine-2,4-dione derivatives.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/658142","offsetInEndSection":120,"text":"[Comparison of the electrophysiological effects of two neuroleptics, melperone and thioridazine, on isolated rat atria.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11152014","offsetInEndSection":69,"text":"[Can antiarrhythmic agents be selected based on mechanism of action?]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1712704","offsetInEndSection":117,"text":"[Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9918445","offsetInEndSection":80,"text":"[Intravenous amiodarone for ventricular arrhythmias: overview and clinical use.]","beginSection":"title"}],"id":"54d4e03a3706e89528000001","body":"Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24373612","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10690412","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2219722","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2837656","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8216734","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9497392","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1905158","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6312049","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7505389","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2110060"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1905158","offsetInEndSection":146,"text":"[Regulation of expression of the genome of bacteriophage M13. Gene V protein regulated translation of the mRNAs encoded by genes I, III, V and X.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6312049","offsetInEndSection":182,"text":"[Characterization of the DNA binding protein encoded by the N-specific filamentous Escherichia coli phage IKe. Binding properties of the protein and nucleotide sequence of the gene.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2219722","offsetInEndSection":106,"text":"[Vaccinia protein kinase 2: a second essential serine\/threonine protein kinase encoded by vaccinia virus.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2110060","offsetInEndSection":101,"text":"[Translational regulation of M13 gene II protein by its cognate single-stranded DNA binding protein.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24373612","offsetInEndSection":116,"text":"[ITIH3 polymorphism may confer susceptibility to psychiatric disorders by altering the expression levels of GLT8D1.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2837656","offsetInEndSection":178,"text":"[Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: mutational analysis of the viral proteins.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9497392","offsetInEndSection":150,"text":"[Role of the acidic carboxyl-terminal domain of the single-stranded DNA-binding protein of bacteriophage T7 in specific protein-protein interactions.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10690412","offsetInEndSection":118,"text":"[Intracellular gene transfer: reduced hydrophobicity facilitates gene transfer for subunit 2 of cytochrome c oxidase.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7505389","offsetInEndSection":135,"text":"[Analysis of genes encoding two unique type IIa immunoglobulin G-binding proteins expressed by a single group A streptococcal isolate.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8216734","offsetInEndSection":127,"text":"[Genetic analysis of carcinogen enhancement of type 5 adenovirus transformation of cloned Fischer rat embryo fibroblast cells.]","beginSection":"title"}],"id":"54d643023706e89528000007","body":"Which is the protein that is encoded by the gene GLT8D1","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24373612","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25461954","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27396837","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19200528","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15368101","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24637430","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25801845","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27439572","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9921901","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19946720"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24373612","offsetInEndSection":116,"text":"[ITIH3 polymorphism may confer susceptibility to psychiatric disorders by altering the expression levels of GLT8D1.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27396837","offsetInEndSection":68,"text":"[The role of the ITIH3 rs2535629 variant in antipsychotic response.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15368101","offsetInEndSection":141,"text":"[SMARCA2 and THAP11: potential candidates for polyglutamine disorders as evidenced from polymorphism and protein-folding simulation studies.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19946720","offsetInEndSection":139,"text":"[COMT Val158Met polymorphism and socioeconomic status interact to predict attention deficit\/hyperactivity problems in children aged 10-14.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24637430","offsetInEndSection":152,"text":"[Exploring the agreement between questionnaire information and DSM-IV diagnoses of comorbid psychopathology in children with autism spectrum disorders.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27439572","offsetInEndSection":66,"text":"[SLC9A9 Co-expression modules in autism-associated brain regions.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25801845","offsetInEndSection":108,"text":"[Interleukin-6 promoter polymorphism interacts with pain and life stress influencing depression phenotypes.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25461954","offsetInEndSection":157,"text":"[Family-based association study of the arsenite methyltransferase gene (AS3MT, rs11191454) in Korean children with attention-deficit hyperactivity disorder.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19200528","offsetInEndSection":83,"text":"[A mega-analysis of genome-wide association studies for major depressive disorder.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9921901","offsetInEndSection":40,"text":"[CCG repeats in cDNAs from human brain.]","beginSection":"title"}],"id":"54d646403706e89528000008","body":"List disorders that have been associated to the polymorphism rs2535629.","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24694947","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22496617","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27686740","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22416063","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25404465","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23428903","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11532935","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8087486","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24577941","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24025256"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22496617","offsetInEndSection":76,"text":"[In vivo imaging of specific drug-target binding at subcellular resolution.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8087486","offsetInEndSection":102,"text":"[Inhibition of PARP-1 by olaparib (AZD2281) increases the radiosensitivity of a lung tumor xenograft.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11532935","offsetInEndSection":118,"text":"[A genetic screen using the PiggyBac transposon in haploid cells identifies Parp1 as a mediator of olaparib toxicity.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24577941","offsetInEndSection":161,"text":"[The use of Olaparib (AZD2281) potentiates SN-38 cytotoxicity in colon cancer cells by indirect inhibition of Rad51-mediated repair of DNA double-strand breaks.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27686740","offsetInEndSection":166,"text":"[Efficacy of poly (ADP-ribose) polymerase inhibitor olaparib against head and neck cancer cells: Predictions of drug sensitivity based on PAR-p53-NF-κB interactions.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23428903","offsetInEndSection":109,"text":"[Linking off-target kinase pharmacology to the differential cellular effects observed among PARP inhibitors.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22416063","offsetInEndSection":113,"text":"[A pharmacodynamic study of the P-glycoprotein antagonist CBT-1® in combination with paclitaxel in solid tumors.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25404465","offsetInEndSection":117,"text":"[PARP inhibitor, olaparib ameliorates acute lung and kidney injury upon intratracheal administration of LPS in mice.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24025256","offsetInEndSection":144,"text":"[Comparative antiproliferative effects of iniparib and olaparib on a panel of triple-negative and non-triple-negative breast cancer cell lines.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24694947","offsetInEndSection":98,"text":"[New insights into PARP inhibitors' effect on cell cycle and homology-directed DNA damage repair.]","beginSection":"title"}],"id":"54d649843706e89528000009","body":"What is the target of the drug Olaparib","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/212921","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8881991","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26764296","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8862346","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7605070","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8972170","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8128981","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1714591","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10998431","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22528185"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8972170","offsetInEndSection":75,"text":"[Charcot-Marie-Tooth disease type 1A: a family study with microsatellites.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26764296","offsetInEndSection":45,"text":"[[Pathology of Charcot-Marie-Tooth Disease].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8862346","offsetInEndSection":65,"text":"[Charcot-Marie-Tooth disease and related inherited neuropathies.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8128981","offsetInEndSection":133,"text":"[Molecular basis of Charcot-Marie-Tooth disease type 1A: gene dosage as a novel mechanism for a common autosomal dominant condition.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/212921","offsetInEndSection":126,"text":"[Charcot-Marie-Tooth disease in northern Sweden: pedigree analysis and the presence of the duplication in chromosome 17p11.2.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10998431","offsetInEndSection":228,"text":"[Charcot-Marie-Tooth disease type 1A (CMT1A) and hereditary neuropathy with liability to pressure palsies (HNPP): reliable detection of the CMT1A duplication and HNPP deletion using 8 microsatellite markers in 2 multiplex PCRs.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7605070","offsetInEndSection":90,"text":"[Understanding Schwann cell-neurone interactions: the key to Charcot-Marie-Tooth disease?]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22528185","offsetInEndSection":169,"text":"[Myelinating and demyelinating phenotype of Trembler-J mouse (a model of Charcot-Marie-Tooth human disease) analyzed by atomic force microscopy and confocal microscopy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1714591","offsetInEndSection":183,"text":"[Exposure at the cell surface is required for gas3\/PMP22 To regulate both cell death and cell spreading: implication for the Charcot-Marie-Tooth type 1A and Dejerine-Sottas diseases.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8881991","offsetInEndSection":129,"text":"[Correlation between the histopathologic, genotypic, and phenotypic features of hereditary peripheral neuropathies in childhood.]","beginSection":"title"}],"id":"54d65b6b3706e8952800000c","body":"List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A).","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17044185","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25166490","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27560777","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19055353","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21696903","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16384548","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16404815","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25160088","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25597799","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27480407"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19055353","offsetInEndSection":130,"text":"[Liquid chromatography quadrupole time-of-flight mass spectrometry characterization of metabolites guided by the METLIN database.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17044185","offsetInEndSection":135,"text":"[Molecular formula and METLIN Personal Metabolite Database matching applied to the identification of compounds generated by LC\/TOF-MS.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16404815","offsetInEndSection":46,"text":"[METLIN: a metabolite mass spectral database.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25166490","offsetInEndSection":55,"text":"[isoMETLIN: a database for isotope-based metabolomics.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27560777","offsetInEndSection":82,"text":"[Smartphone Analytics: Mobilizing the Lab into the Cloud for Omic-Scale Analyses.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21696903","offsetInEndSection":133,"text":"[Comprehensive chemical analysis of Venenum Bufonis by using liquid chromatography\/electrospray ionization tandem mass spectrometry.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25597799","offsetInEndSection":142,"text":"[Untargeted metabolomic analysis using liquid chromatography quadrupole time-of-flight mass spectrometry for non-volatile profiling of wines.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16384548","offsetInEndSection":112,"text":"[XCMS2: processing tandem mass spectrometry data for metabolite identification and structural characterization.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25160088","offsetInEndSection":82,"text":"[Autonomous metabolomics for rapid metabolite identification in global profiling.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27480407","offsetInEndSection":140,"text":"[Nontargeted Screening Method for Illegal Additives Based on Ultrahigh-Performance Liquid Chromatography-High-Resolution Mass Spectrometry.]","beginSection":"title"}],"id":"54d662113706e8952800000d","body":"What is the content of the METLIN database","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19782094","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27764116","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22197679","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22086292","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27001251","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17652592","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22138213","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16904710","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26263069","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19482271"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22138213","offsetInEndSection":102,"text":"[Body knowledge in brain-damaged children: a double-dissociation in self and other's body processing.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17652592","offsetInEndSection":93,"text":"[Transcranial magnetic stimulation reveals two cortical pathways for visual body processing.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19482271","offsetInEndSection":85,"text":"[Selective impairment of self body-parts processing in right brain-damaged patients.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27001251","offsetInEndSection":100,"text":"[Holistic processing for bodies and body parts: New evidence from stereoscopic depth manipulations.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22086292","offsetInEndSection":149,"text":"[Body integrity identity disorder: deranged body processing, right fronto-parietal dysfunction, and phenomenological experience of body incongruity.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26263069","offsetInEndSection":48,"text":"[The perception of emotion in body expressions.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16904710","offsetInEndSection":74,"text":"[Body inversion effect without body sense: insights from deafferentation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19782094","offsetInEndSection":95,"text":"[Body schematics: on the role of the body schema in embodied lexical-semantic representations.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22197679","offsetInEndSection":126,"text":"[Differential processing of social chemosignals obtained from potential partners in regards to gender and sexual orientation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27764116","offsetInEndSection":127,"text":"[My Body Looks Like That Girl's: Body Mass Index Modulates Brain Activity during Body Image Self-Reflection among Young Women.]","beginSection":"title"}],"id":"54d8e59f4b1fd0d33c000001","body":"What is a P-body (processing body)","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27654337","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25754998","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27714257","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25262806","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25203970","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24002361","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25114537","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24554919","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27151308","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19220750"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25754998","offsetInEndSection":45,"text":"[Bactericidal mode of action of bedaquiline.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25203970","offsetInEndSection":98,"text":"[Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19220750","offsetInEndSection":113,"text":"[Mode of Action of Clofazimine and Combination Therapy with Benzothiazinones against Mycobacterium tuberculosis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27714257","offsetInEndSection":60,"text":"[New synthetic approaches towards analogues of bedaquiline.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27151308","offsetInEndSection":76,"text":"[New agents for the treatment of drug-resistant Mycobacterium tuberculosis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25114537","offsetInEndSection":80,"text":"[New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24002361","offsetInEndSection":47,"text":"[Antibiotics in the clinical pipeline in 2013.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24554919","offsetInEndSection":75,"text":"[Bedaquiline: A novel drug to combat multiple drug-resistant tuberculosis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25262806","offsetInEndSection":69,"text":"[Bedaquiline: a new hope to treat multi-drug resistant tuberculosis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27654337","offsetInEndSection":135,"text":"[A Multilaboratory, Multicountry Study To Determine Bedaquiline MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing.]","beginSection":"title"}],"id":"54d9071a4b1fd0d33c000007","body":"What is the mode of action of bedaquiline","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18298130","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27138023","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21348536","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17654661","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10811853","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27889561","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27803792","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25671117","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15175031","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21824072"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18298130","offsetInEndSection":140,"text":"[Mepolizumab: 240563, anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21348536","offsetInEndSection":98,"text":"[Pharmacokinetics and pharmacodynamics of mepolizumab, an anti-interleukin-5 monoclonal antibody.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27138023","offsetInEndSection":133,"text":"[Pharmacokinetics and pharmacodynamics of mepolizumab, an anti-interleukin 5 monoclonal antibody, in healthy Japanese male subjects.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27889561","offsetInEndSection":153,"text":"[Inhibition of interleukin-5 induced false positive anti-drug antibody responses against mepolizumab through the use of a competitive blocking antibody.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10811853","offsetInEndSection":90,"text":"[A halotyrosine antibody that detects increased protein modifications in asthma patients.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15175031","offsetInEndSection":129,"text":"[Intravenous anti-IL-5 monoclonal antibody reduces eosinophils and tenascin deposition in allergen-challenged human atopic skin.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27803792","offsetInEndSection":97,"text":"[Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17654661","offsetInEndSection":140,"text":"[A critical appraisal of conventional and investigational drug therapy in patients with hypereosinophilic syndrome and clonal eosinophilia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25671117","offsetInEndSection":37,"text":"[Tailored therapy for severe asthma.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21824072","offsetInEndSection":71,"text":"[Current update on eosinophilic lung diseases and anti-IL-5 treatment.]","beginSection":"title"}],"id":"54d907c84b1fd0d33c000008","body":"Which molecule is targeted by a monoclonal antibody Mepolizumab","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8341310","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23614923","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15465396","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1672807","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12465067","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17579361","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8351010","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18609312","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11835466","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16242937"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8341310","offsetInEndSection":59,"text":"[Neuropathology of lubag (x-linked dystonia parkinsonism).]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18609312","offsetInEndSection":121,"text":"[Neuropsychological profile of a Filipino gentleman with X-linked dystonia-parkinsonism: a case report of Lubag disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12465067","offsetInEndSection":61,"text":"[Phenomenology of \"Lubag\" or X-linked dystonia-parkinsonism.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1672807","offsetInEndSection":134,"text":"[Genetic mapping of \"Lubag\" (X-linked dystonia-parkinsonism) in a Filipino kindred to the pericentromeric region of the X chromosome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8351010","offsetInEndSection":79,"text":"[Phenotypic expression of X-linked dystonia-parkinsonism (lubag) in two women.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16242937","offsetInEndSection":84,"text":"[First case report of X linked dystonia parkinsonism (XDP) or 'lubag' in Australia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15465396","offsetInEndSection":88,"text":"[Smell testing is abnormal in 'lubag' or X-linked dystonia-parkinsonism: a pilot study.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23614923","offsetInEndSection":103,"text":"[Anesthesia for deep brain stimulation in a patient with X-linked dystonia-parkinsonism\/Lubag disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17579361","offsetInEndSection":117,"text":"[First case of X-linked dystonia-parkinsonism (\"Lubag\") to demonstrate a response to bilateral pallidal stimulation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11835466","offsetInEndSection":98,"text":"[X-linked dystonia (\"Lubag\") presenting predominantly with parkinsonism: a more benign phenotype?]","beginSection":"title"}],"id":"54df695b1388e8454a000004","body":"What is the synonym of the lubag disease","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21398638","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23601106","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15668174","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16025511","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26182081","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15159405","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8895199","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11237011","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22042642","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11237011"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15159405","offsetInEndSection":98,"text":"[Inhibition of LINE-1 and Alu retrotransposition by exosomes encapsidating APOBEC3G and APOBEC3F.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21398638","offsetInEndSection":103,"text":"[APOBEC3G oligomerization is associated with the inhibition of both Alu and LINE-1 retrotransposition.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23601106","offsetInEndSection":99,"text":"[Modulation of LINE-1 and Alu\/SVA retrotransposition by Aicardi-Goutières syndrome-related SAMHD1.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16025511","offsetInEndSection":80,"text":"[Cellular inhibitors of long interspersed element 1 and Alu retrotransposition.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15668174","offsetInEndSection":61,"text":"[Selective inhibition of Alu retrotransposition by APOBEC3G.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8895199","offsetInEndSection":59,"text":"[LINE-1 ORF1 protein enhances Alu SINE retrotransposition.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26182081","offsetInEndSection":81,"text":"[The Zinc-Finger Antiviral Protein ZAP Inhibits LINE and Alu Retrotransposition.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11237011","offsetInEndSection":94,"text":"[The RNA polymerase dictates ORF1 requirement and timing of LINE and SINE retrotransposition.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22042642","offsetInEndSection":104,"text":"[Molecular reconstruction of extinct LINE-1 elements and their interaction with nonautonomous elements.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11237011","offsetInEndSection":75,"text":"[Retrotransposition of marked SVA elements by human L1s in cultured cells.]","beginSection":"title"}],"id":"54dfbed11388e8454a000008","body":"Which proteins induce inhibition of LINE-1 and Alu retrotransposition","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17020885","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16141076","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12167863","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16527742","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22203821","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11907217","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18069336","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6574464","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2441266","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15496550"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11907217","offsetInEndSection":119,"text":"[Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22203821","offsetInEndSection":94,"text":"[Structural Features of Antiviral APOBEC3 Proteins are Linked to Their Functional Activities.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2441266","offsetInEndSection":77,"text":"[APOBEC3 versus Retroviruses, Immunity versus Invasion: Clash of the Titans.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6574464","offsetInEndSection":81,"text":"[Inhibition of alpharetrovirus replication by a range of human APOBEC3 proteins.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15496550","offsetInEndSection":82,"text":"[Evolution of the AID\/APOBEC family of polynucleotide (deoxy)cytidine deaminases.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17020885","offsetInEndSection":89,"text":"[Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16141076","offsetInEndSection":81,"text":"[HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12167863","offsetInEndSection":115,"text":"[Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18069336","offsetInEndSection":62,"text":"[[Vertebrate immunity: mutator proteins and their evolution].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16527742","offsetInEndSection":80,"text":"[APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons.]","beginSection":"title"}],"id":"54dfc6501388e8454a000009","body":"Which are the main functions of the APOBEC3 family of proteins","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12970355","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1357189","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17121840","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14527406","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16580072","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18851679","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11863358","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21300806","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9811770","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12167863"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1357189","offsetInEndSection":89,"text":"[NF-IL6 (C\/EBPbeta) induces HIV-1 replication by inhibiting cytidine deaminase APOBEC3G.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16580072","offsetInEndSection":126,"text":"[HIV-1 Vif protein blocks the cytidine deaminase activity of B-cell specific AID in E. coli by a similar mechanism of action.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17121840","offsetInEndSection":139,"text":"[APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9811770","offsetInEndSection":82,"text":"[APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18851679","offsetInEndSection":181,"text":"[Quantification of deaminase activity-dependent and -independent restriction of HIV-1 replication mediated by APOBEC3F and APOBEC3G through experimental-mathematical investigation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21300806","offsetInEndSection":80,"text":"[Biochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14527406","offsetInEndSection":139,"text":"[Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12970355","offsetInEndSection":108,"text":"[The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12167863","offsetInEndSection":160,"text":"[Signals in APOBEC3F N-terminal and C-terminal deaminase domains each contribute to encapsidation in HIV-1 virions and are both required for HIV-1 restriction.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11863358","offsetInEndSection":84,"text":"[Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.]","beginSection":"title"}],"id":"54dfcdf81388e8454a00000a","body":"What is the mechanism of action of APOBEC3G cytidine deaminase to inhibit HIV-1 replication","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3497453","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11595597","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12039955","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15219863","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12167863","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7983731","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8289374","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16438045","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15152192","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12832479"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12039955","offsetInEndSection":132,"text":"[Functional neutralization of HIV-1 Vif protein by intracellular immunization inhibits reverse transcription and viral replication.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8289374","offsetInEndSection":215,"text":"[gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15152192","offsetInEndSection":113,"text":"[Evolution of HIV-1 isolates that use a novel Vif-independent mechanism to resist restriction by human APOBEC3G.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3497453","offsetInEndSection":176,"text":"[Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16438045","offsetInEndSection":151,"text":"[The middle to 3' end of the HIV-1 vif gene sequence is important for vif biological activity and could be used for antisense oligonucleotide targets.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7983731","offsetInEndSection":103,"text":"[The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15219863","offsetInEndSection":184,"text":"[Intracellular expression of antisense RNA transcripts complementary to the human immunodeficiency virus type-1 vif gene inhibits viral replication in infected T-lymphoblastoid cells.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12167863","offsetInEndSection":183,"text":"[Regulation of Vif mRNA splicing by human immunodeficiency virus type 1 requires 5' splice site D2 and an exonic splicing enhancer to counteract cellular restriction factor APOBEC3G.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12832479","offsetInEndSection":126,"text":"[HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11595597","offsetInEndSection":144,"text":"[Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity.]","beginSection":"title"}],"id":"54dfce9b1388e8454a00000b","body":"What is the mechanism by which HIV-1-encoded Vif protein allows virus replication","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24667738","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22805244","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9568761","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24507694","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24138953","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2067610","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27910945","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17275668","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9795959","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25143481"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24507694","offsetInEndSection":99,"text":"[Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25143481","offsetInEndSection":114,"text":"[Everolimus Treatment for an Early Infantile Subependymal Giant Cell Astrocytoma With Tuberous Sclerosis Complex.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17275668","offsetInEndSection":82,"text":"[Neonatal subependymal giant cell astrocytoma: new case and review of literature.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9568761","offsetInEndSection":93,"text":"[Early diagnosis of subependymal giant cell astrocytoma in patients with tuberous sclerosis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22805244","offsetInEndSection":142,"text":"[Everolimus for tumor recurrence after surgical resection for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9795959","offsetInEndSection":86,"text":"[Subependymal giant-cell astrocytoma associated with tuberous sclerosis: case report.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2067610","offsetInEndSection":91,"text":"[Subependymal giant cell astrocytoma: a clinical, pathological, and flow cytometric study.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24138953","offsetInEndSection":168,"text":"[Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24667738","offsetInEndSection":139,"text":"[The burden of subependymal giant cell astrocytomas associated with tuberous sclerosis complex: results of a patient and caregiver survey.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27910945","offsetInEndSection":188,"text":"[Thyroid transcription factor-1 distinguishes subependymal giant cell astrocytoma from its mimics and supports its cell origin from the progenitor cells in the medial ganglionic eminence.]","beginSection":"title"}],"id":"54e061ee1388e8454a00000c","body":"List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21584670","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27816650","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27705929","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21358688","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22448704","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26301717","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16418499","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18176613","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22245597","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19430496"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27705929","offsetInEndSection":184,"text":"[A 5-day cytoreductive chemotherapy followed by haplo-identical hsct (FA5-BUCY) as a tumor-ablative regimen improved the survival of patients with advanced hematological malignancies.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21584670","offsetInEndSection":214,"text":"[Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27816650","offsetInEndSection":298,"text":"[Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate- or High-Risk Acute Myeloid Leukemia in Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26301717","offsetInEndSection":157,"text":"[FLAMSA reduced-intensity conditioning is equally effective in AML patients with primary induction failure as well as in first or second complete remission.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18176613","offsetInEndSection":198,"text":"[High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22245597","offsetInEndSection":205,"text":"[Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimen.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22448704","offsetInEndSection":268,"text":"[[Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16418499","offsetInEndSection":219,"text":"[Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19430496","offsetInEndSection":224,"text":"[Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21358688","offsetInEndSection":99,"text":"[Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot study.]","beginSection":"title"}],"id":"54e071e11388e8454a00000d","body":"Which agents are included in the FLAMSA chemotherapy regimen","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10999419","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12408960","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16527742","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24938436","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18925379","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26291654","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21828060","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10899969","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11371603","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27026073"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24938436","offsetInEndSection":101,"text":"[Loss of transcriptional control over endogenous retroelements during reprogramming to pluripotency.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27026073","offsetInEndSection":77,"text":"[Immune responses to endogenous retroelements: taking the bad with the good.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10999419","offsetInEndSection":94,"text":"[Recent amplification of the kangaroo endogenous retrovirus, KERV, limited to the centromere.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26291654","offsetInEndSection":56,"text":"[Two classes of short interfering RNA in RNA silencing.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10899969","offsetInEndSection":70,"text":"[Endogenous targets of transcriptional gene silencing in Arabidopsis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21828060","offsetInEndSection":72,"text":"[Selective changes of retroelement expression in human prostate cancer.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16527742","offsetInEndSection":80,"text":"[APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18925379","offsetInEndSection":114,"text":"[Envelope-like retrotransposons in the plant kingdom: evidence of their presence in gymnosperms (Pinus pinaster).]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11371603","offsetInEndSection":104,"text":"[Retroelement distributions in the human genome: variations associated with age and proximity to genes.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12408960","offsetInEndSection":130,"text":"[A novel endogenous retrovirus-related element in the human genome resembles a DNA transposon: evidence for an evolutionary link?]","beginSection":"title"}],"id":"54e0ac041388e8454a00000f","body":"Which classes of endogenous retroelements are known to date","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9368759","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19845642","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17166910","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23486239","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27818121","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15893695","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27643540","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17672864","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24476821","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25142126"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15893695","offsetInEndSection":58,"text":"[APOBEC3B and AID have similar nuclear import mechanisms.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23486239","offsetInEndSection":63,"text":"[APOBEC3B is an enzymatic source of mutation in breast cancer.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27818121","offsetInEndSection":85,"text":"[Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17672864","offsetInEndSection":131,"text":"[Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25142126","offsetInEndSection":78,"text":"[Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24476821","offsetInEndSection":70,"text":"[Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19845642","offsetInEndSection":99,"text":"[The role of amino-terminal sequences in cellular localization and antiviral activity of APOBEC3B.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9368759","offsetInEndSection":105,"text":"[Two regions within the amino-terminal half of APOBEC3G cooperate to determine cytoplasmic localization.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17166910","offsetInEndSection":111,"text":"[Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27643540","offsetInEndSection":131,"text":"[Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors.]","beginSection":"title"}],"id":"54e0ace81388e8454a000010","body":"Is APOBEC3B protein predominantly cytoplasmic or nuclear","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10381257","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11027586","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9045676","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15205677","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10618712","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18670869","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1103152","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8660965","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15087125","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16147884"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9045676","offsetInEndSection":109,"text":"[Metaxin is a component of a preprotein import complex in the outer membrane of the mammalian mitochondrion.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11027586","offsetInEndSection":131,"text":"[Functional analysis of human metaxin in mitochondrial protein import in cultured cells and its relationship with the Tom complex.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10618712","offsetInEndSection":67,"text":"[Metaxin is required for tumor necrosis factor-induced cell death.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8660965","offsetInEndSection":76,"text":"[Structure and organization of the human metaxin gene (MTX) and pseudogene.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10381257","offsetInEndSection":121,"text":"[Metaxin 1 interacts with metaxin 2, a novel related protein associated with the mammalian mitochondrial outer membrane.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15087125","offsetInEndSection":112,"text":"[The zebrafish metaxin 3 gene (mtx3): cDNA and protein structure, and comparison to zebrafish metaxins 1 and 2.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16147884","offsetInEndSection":123,"text":"[Characterization of the cDNA and amino acid sequences of Xenopus Metaxin 3, and relationship to Xenopus Metaxins 1 and 2.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18670869","offsetInEndSection":112,"text":"[Targeting and insertion of the cholesterol-binding translocator protein into the outer mitochondrial membrane.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1103152","offsetInEndSection":116,"text":"[Metaxin deficiency alters mitochondrial membrane permeability and leads to resistance to TNF-induced cell killing.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15205677","offsetInEndSection":59,"text":"[Conserved roles of Sam50 and metaxins in VDAC biogenesis.]","beginSection":"title"}],"id":"54e0ba781388e8454a000011","body":"Where is the metaxin complex localized","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22249003","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23146910","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27395338","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25297456","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20818862","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27826831","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23856460","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23788266","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23371447","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27163497"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25297456","offsetInEndSection":77,"text":"[Preclinical assessment of Orteronel(®), a CYP17A1 enzyme inhibitor in rats.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20818862","offsetInEndSection":49,"text":"[Orteronel for the treatment of prostate cancer.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23788266","offsetInEndSection":184,"text":"[Development and validation of an RP-HPLC method for the quantitation of Orteronel (TAK-700), a CYP17A1 enzyme inhibitor, in rat plasma and its application to a pharmacokinetic study.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23146910","offsetInEndSection":99,"text":"[Effect of a novel 17,20-lyase inhibitor, orteronel (TAK-700), on androgen synthesis in male rats.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27826831","offsetInEndSection":116,"text":"[Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23371447","offsetInEndSection":134,"text":"[Targeting the adrenal gland in castration-resistant prostate cancer: a case for orteronel, a selective CYP-17 17,20-lyase inhibitor.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22249003","offsetInEndSection":178,"text":"[Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23856460","offsetInEndSection":213,"text":"[Effect of an investigational CYP17A1 inhibitor, orteronel (TAK-700), on estrogen- and corticoid-synthesis pathways in hypophysectomized female rats and on the serum estradiol levels in female cynomolgus monkeys.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27163497","offsetInEndSection":172,"text":"[A Phase 1, Randomized, Single-Dose Crossover Pharmacokinetic Study to Investigate the Effect of Food Intake on Absorption of Orteronel (TAK-700) in Healthy Male Subjects.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27395338","offsetInEndSection":82,"text":"[Specificity of anti-prostate cancer CYP17A1 inhibitors on androgen biosynthesis.]","beginSection":"title"}],"id":"54e0c3e71388e8454a000013","body":"Which enzyme is inhibited by Orteronel","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27848220","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26692765","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27660454","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25824308","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27096698","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27481380","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26643308","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22435370","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27066336","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24477778"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26643308","offsetInEndSection":41,"text":"[Evolocumab: A Review in Hyperlipidemia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25824308","offsetInEndSection":56,"text":"[Evolocumab (AMG 145) for primary hypercholesterolemia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27660454","offsetInEndSection":75,"text":"[Retargeting the management of hypercholesterolemia - focus on evolocumab.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22435370","offsetInEndSection":95,"text":"[Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27066336","offsetInEndSection":95,"text":"[Evolocumab lowers LDL-C safely and effectively when self-administered in the at-home setting.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27848220","offsetInEndSection":156,"text":"[Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24477778","offsetInEndSection":234,"text":"[Design and rationale of the GAUSS-2 study trial: a double-blind, ezetimibe-controlled phase 3 study of the efficacy and tolerability of evolocumab (AMG 145) in subjects with hypercholesterolemia who are intolerant of statin therapy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26692765","offsetInEndSection":65,"text":"[Low High-Density Lipoprotein and Risk of Myocardial Infarction.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27096698","offsetInEndSection":164,"text":"[The New Face of Hyperlipidemia Management: Proprotein Convertase Subtilisin\/Kexin Inhibitors (PCSK-9) and Their Emergent Role As An Alternative To Statin Therapy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27481380","offsetInEndSection":113,"text":"[Drugs for hypercholesterolaemia - from statins to pro-protein convertase subtilisin kexin 9 (PCSK9) inhibition.]","beginSection":"title"}],"id":"54e0d1491388e8454a000014","body":"Which enzyme is targeted by Evolocumab","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27420998","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27299434","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24677511","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26664127","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26817498","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23253932","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26202871","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27142710","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27255593","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27785085"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27299434","offsetInEndSection":47,"text":"[Secukinumab: A Review in Psoriatic Arthritis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27255593","offsetInEndSection":50,"text":"[Secukinumab: A Review in Ankylosing Spondylitis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24677511","offsetInEndSection":127,"text":"[The selective anti-IL17A monoclonal antibody secukinumab (AIN457) attenuates IL17A-induced levels of IL6 in human astrocytes.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26202871","offsetInEndSection":63,"text":"[Secukinumab: a review in moderate to severe plaque psoriasis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27420998","offsetInEndSection":151,"text":"[Effect of IL-17 monoclonal antibody Secukinumab combined with IL-35 blockade of Notch signaling pathway on the invasive capability of hepatoma cells.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27142710","offsetInEndSection":128,"text":"[Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26817498","offsetInEndSection":183,"text":"[Secukinumab, a novel anti-IL-17A antibody, shows low immunogenicity potential in human in vitro assays comparable to other marketed biotherapeutics with low clinical immunogenicity.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26664127","offsetInEndSection":77,"text":"[Profile of secukinumab in the treatment of psoriasis: current perspectives.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23253932","offsetInEndSection":68,"text":"[Effect of IL-17A blockade with secukinumab in autoimmune diseases.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27785085","offsetInEndSection":102,"text":"[Treatment challenges in the management of moderate-to-severe plaque psoriasis - role of secukinumab.]","beginSection":"title"}],"id":"54e0d7471388e8454a000015","body":"Which molecule is targeted by a monoclonal antibody Secukinumab","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15175162","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15195149","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9407025","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10235266","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11834806","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6888276","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18483201","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18558619","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9989412","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12914769"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6888276","offsetInEndSection":54,"text":"[Purification of transcription cofactor complex CRSP.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9989412","offsetInEndSection":105,"text":"[The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15195149","offsetInEndSection":78,"text":"[Distinct conformational states of nuclear receptor-bound CRSP-Med complexes.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11834806","offsetInEndSection":83,"text":"[Structure, function, and activator-induced conformations of the CRSP coactivator.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15175162","offsetInEndSection":96,"text":"[Structure and function of CRSP\/Med2; a promoter-selective transcriptional coactivator complex.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10235266","offsetInEndSection":91,"text":"[Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12914769","offsetInEndSection":95,"text":"[Identification of second and third calcitonin receptor-stimulating peptides in porcine brain.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18483201","offsetInEndSection":111,"text":"[Identification and biological activity of ovine and caprine calcitonin receptor-stimulating peptides 1 and 2.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18558619","offsetInEndSection":132,"text":"[Genomic and expression analysis of canine calcitonin receptor-stimulating peptides and calcitonin\/calcitonin gene-related peptide.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9407025","offsetInEndSection":95,"text":"[Human CRSP interacts with RNA polymerase II CTD and adopts a specific CTD-bound conformation.]","beginSection":"title"}],"id":"54e0dfa91388e8454a000018","body":"List components of the CRSP\/Med complex.","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17373907","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16487696","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23851486","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23740402","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16303559","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9184220","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16358406","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16361707","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12805219","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11402062"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23851486","offsetInEndSection":177,"text":"[Small molecule inhibitor of formin homology 2 domains (SMIFH2) reveals the roles of the formin family of proteins in spindle assembly and asymmetric division in mouse oocytes.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12805219","offsetInEndSection":33,"text":"[mDia1-3 in mammalian filopodia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16487696","offsetInEndSection":37,"text":"[Rho GTPases in animal cell mitosis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9184220","offsetInEndSection":165,"text":"[Distinct actions and cooperative roles of ROCK and mDia in Rho small G protein-induced reorganization of the actin cytoskeleton in Madin-Darby canine kidney cells.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11402062","offsetInEndSection":117,"text":"[Force-induced myofibroblast differentiation through collagen receptors is dependent on mammalian diaphanous (mDia).]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16303559","offsetInEndSection":116,"text":"[A role for mammalian diaphanous-related formins in complement receptor (CR3)-mediated phagocytosis in macrophages.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16358406","offsetInEndSection":129,"text":"[Small-molecule agonists of mammalian Diaphanous-related (mDia) formins reveal an effective glioblastoma anti-invasion strategy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17373907","offsetInEndSection":124,"text":"[mDia2 induces the actin scaffold for the contractile ring and stabilizes its position during cytokinesis in NIH 3T3 cells.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23740402","offsetInEndSection":67,"text":"[LIN7-IRSp53: A novel pathway for filopodia and neurite formation?]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16361707","offsetInEndSection":162,"text":"[The basic region of the diaphanous-autoregulatory domain (DAD) is required for autoregulatory interactions with the diaphanous-related formin inhibitory domain.]","beginSection":"title"}],"id":"54e0e902ae9738404b000001","body":"What family do mDia proteins belong in","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22696272","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25821090","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9557891","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16915311","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21959861","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22353005","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18324963","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17052632","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19937459","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24443025"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24443025","offsetInEndSection":29,"text":"[The Ehlers-Danlos syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22353005","offsetInEndSection":57,"text":"[The Ehlers-Danlos syndrome, a disorder with many faces.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16915311","offsetInEndSection":60,"text":"[[Ehlers-Danlos syndrome--diagnosis and subclassification].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18324963","offsetInEndSection":46,"text":"[Ehlers-Danlos syndrome--a historical review.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17052632","offsetInEndSection":90,"text":"[Ehlers-Danlos syndrome: classifications, oral manifestations, and dental considerations.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21959861","offsetInEndSection":127,"text":"[Well-defined clinical presentation of Ehlers-Danlos syndrome in patients with tenascin-X deficiency:  a report of four cases.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9557891","offsetInEndSection":142,"text":"[Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK).]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19937459","offsetInEndSection":124,"text":"[Joint position sense and vibratory perception sense in patients with Ehlers-Danlos syndrome type III (hypermobility type).]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25821090","offsetInEndSection":181,"text":"[Differential diagnosis and diagnostic flow chart of joint hypermobility syndrome\/ehlers-danlos syndrome hypermobility type compared to other heritable connective tissue disorders.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22696272","offsetInEndSection":156,"text":"[Comprehensive molecular analysis demonstrates type V collagen mutations in over 90% of patients with classic EDS and allows to refine diagnostic criteria.]","beginSection":"title"}],"id":"54e1252fae9738404b000003","body":"What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25103963","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21851252","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21217464","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25489549","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15607555","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3183093","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18972565","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25122555","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22696272","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20576846"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25103963","offsetInEndSection":118,"text":"[Tendon protein synthesis rate in classic Ehlers-Danlos patients can be stimulated with insulin-like growth factor-I.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25489549","offsetInEndSection":152,"text":"[Functional adaptation of tendon and skeletal muscle to resistance training in three patients with genetically verified classic Ehlers Danlos Syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25122555","offsetInEndSection":147,"text":"[Low tendon stiffness and abnormal ultrastructure distinguish classic Ehlers-Danlos syndrome from benign joint hypermobility syndrome in patients.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18972565","offsetInEndSection":108,"text":"[COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers-Danlos syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21851252","offsetInEndSection":119,"text":"[Targeted deletion of collagen V in tendons and ligaments results in a classic Ehlers-Danlos syndrome joint phenotype.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21217464","offsetInEndSection":71,"text":"[Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3183093","offsetInEndSection":137,"text":"[The Ehlers-Danlos syndrome: recognition, characterization, and importance of a milder variant of the classic form. A preliminary study.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22696272","offsetInEndSection":147,"text":"[Homozygosity and Heterozygosity for Null Col5a2 Alleles Produce Embryonic Lethality and a Novel Classic Ehlers-Danlos Syndrome-Related Phenotype.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20576846","offsetInEndSection":137,"text":"[Muscle characteristics and altered myofascial force transmission in tenascin-X-deficient mice, a mouse model of Ehlers-Danlos syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15607555","offsetInEndSection":91,"text":"[A novel therapeutic strategy for Ehlers-Danlos syndrome based on nutritional supplements.]","beginSection":"title"}],"id":"54e12ae3ae9738404b000004","body":"Is insulin-like growth factor-I (IGF-I) able to affect tendon protein synthesis in classic Ehlers-Danlos syndrome patients","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18508806","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21910227","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22696272","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14557872","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10429946","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1297453","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15199158","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11566270","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11375892","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1460034"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18508806","offsetInEndSection":116,"text":"[Analysis of a gene co-expression network establishes robust association between Col5a2 and ischemic heart disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11375892","offsetInEndSection":88,"text":"[Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1460034","offsetInEndSection":142,"text":"[Identification of an upstream regulatory region essential for cell type-specific transcription of the pro-alpha 2(V) collagen gene (COL5A2).]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14557872","offsetInEndSection":164,"text":"[Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11566270","offsetInEndSection":138,"text":"[Genomic organization of the human COL3A1 and COL5A2 genes: COL5A2 has evolved differently than the other minor fibrillar collagen genes.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22696272","offsetInEndSection":147,"text":"[Homozygosity and Heterozygosity for Null Col5a2 Alleles Produce Embryonic Lethality and a Novel Classic Ehlers-Danlos Syndrome-Related Phenotype.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15199158","offsetInEndSection":147,"text":"[Hemizygous deletion of COL3A1, COL5A2, and MSTN causes a complex phenotype with aortic dissection: a lesson for and from true haploinsufficiency.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10429946","offsetInEndSection":172,"text":"[B-Myb represses trans-activation of the Col5A2 collagen promoter indirectly via inhibition of binding of factors interacting with positive elements within the first exon.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21910227","offsetInEndSection":68,"text":"[Copy number variation in patients with cervical artery dissection.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1297453","offsetInEndSection":100,"text":"[Localization of pro-alpha 2(V) collagen transcripts in the tissues of the developing mouse embryo.]","beginSection":"title"}],"id":"54e12c30ae9738404b000005","body":"Is COL5A2 gene associated to ischemic heart disease","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9056591","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12342313","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25395817","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26688897","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24218053","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18579013","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3626003","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24040485","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24589497","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24391396"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24040485","offsetInEndSection":90,"text":"[Impact of brand-name drug worship and expectation psychology on antidepressant efficacy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18579013","offsetInEndSection":30,"text":"[Generic antiepileptic drugs.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25395817","offsetInEndSection":140,"text":"[Riociguat (adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24589497","offsetInEndSection":49,"text":"[Riociguat (Adempas) for pulmonary hypertension.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12342313","offsetInEndSection":47,"text":"[Generic OCs bioequivalent, but much maligned.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3626003","offsetInEndSection":46,"text":"[Generic drugs and the prescribing physician.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26688897","offsetInEndSection":112,"text":"[Riociguat (Adempas). Chronic thromboembolic pulmonary hypertension with markedly restricted physical activity.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9056591","offsetInEndSection":42,"text":"[Meta-analysis for bioequivalence review.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24218053","offsetInEndSection":35,"text":"[Riociguat: first global approval.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24391396","offsetInEndSection":33,"text":"[Pharmaceutical approval update.]","beginSection":"title"}],"id":"54e1bdacae9738404b000009","body":"What is generic name of drug Adempas","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23701638","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11070527","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25967464","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27813265","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23737894","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22211640","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17690870","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17437604","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23605905","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16232094"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27813265","offsetInEndSection":129,"text":"[Association of stroke risk biomarkers with stroke symptoms: the Reasons for Geographic and Racial Differences in Stroke cohort.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22211640","offsetInEndSection":137,"text":"[The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23605905","offsetInEndSection":181,"text":"[Ischemic stroke functional outcomes are independently associated with C-reactive protein concentrations and cognitive outcomes with triiodothyronine concentrations: a pilot study.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17437604","offsetInEndSection":108,"text":"[The influence of anaemia on stroke prognosis and its relation to N-terminal pro-brain natriuretic peptide.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16232094","offsetInEndSection":148,"text":"[Analytical evaluation of the Dade Behring Dimension RxL automated N-Terminal proBNP (NT-proBNP) method and comparison with the Roche Elecsys 2010.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11070527","offsetInEndSection":104,"text":"[Impact of Modifiable Risk Factors on B-type Natriuretic Peptide and Cardiac Troponin T Concentrations.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25967464","offsetInEndSection":151,"text":"[Role of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and inteleukin-6 in predicting a poor outcome after a stroke.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17690870","offsetInEndSection":86,"text":"[Miniaturized monolithic disks for immunoadsorption of cardiac biomarkers from serum.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23701638","offsetInEndSection":95,"text":"[Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23737894","offsetInEndSection":83,"text":"[NT-ProBNP levels are moderately increased in acute high-altitude pulmonary edema.]","beginSection":"title"}],"id":"54e1c5d5ae9738404b00000b","body":"What is the association between proBNP serum concentrations and stroke outcomes","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21285669","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22522051","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19279537","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16300168","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23174623","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19066408","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20413453","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27468152","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26417326","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24420538"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20413453","offsetInEndSection":83,"text":"[Effect of verapamil on the pharmacokinetics of aliskiren in healthy participants.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16300168","offsetInEndSection":113,"text":"[The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21285669","offsetInEndSection":66,"text":"[Potential benefits of aliskiren beyond blood pressure reduction.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19066408","offsetInEndSection":85,"text":"[Pharmacokinetics and pharmacodynamics of aliskiren, an oral direct renin inhibitor.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27468152","offsetInEndSection":94,"text":"[Conformational Properties and Energetic Analysis of Aliskiren in Solution and Receptor Site.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19279537","offsetInEndSection":45,"text":"[Aliskiren-induced QT interval prolongation.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24420538","offsetInEndSection":136,"text":"[Aliskiren reduces myocardial ischemia-reperfusion injury by a bradykinin B2 receptor- and angiotensin AT2 receptor-mediated mechanism.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23174623","offsetInEndSection":94,"text":"[Aliskiren inhibits experimental venous thrombosis in two-kidney one- clip hypertensive rats.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22522051","offsetInEndSection":103,"text":"[How well do aliskiren's purported mechanisms track its effects on cardiovascular and renal disorders?]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26417326","offsetInEndSection":59,"text":"[Renin inhibitors in diabetes and hypertension: an update.]","beginSection":"title"}],"id":"54e221f6ae9738404b000010","body":"Describe the mechanism of action of aliskiren. ","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21217464","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10906878","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10815681","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2343586","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2049575","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11704406","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6259441","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9259907","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7086195","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/5772518"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9259907","offsetInEndSection":46,"text":"[Ehlers-Danlos syndrome type II in pregnancy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2343586","offsetInEndSection":124,"text":"[[Structural characteristics of collagens from the skin and rib cartilage of patients with Ehlers-Danlos syndrome type II].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/5772518","offsetInEndSection":106,"text":"[An unbalanced (6q;13q) translocation in a male with clinical features of Ehlers-Danlos type II syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2049575","offsetInEndSection":167,"text":"[Segregation analysis of the structural genes of the major fibrillar collagens provides further evidence of molecular heterogeneity in type II Ehlers-Danlos syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21217464","offsetInEndSection":71,"text":"[Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11704406","offsetInEndSection":78,"text":"[Intracranial aneurysms in Ehlers-Danlos syndrome type IV in early childhood.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10906878","offsetInEndSection":55,"text":"[Orthopaedic manifestations of Ehlers-Danlos syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10815681","offsetInEndSection":101,"text":"[Type IV Ehlers-Danlos Syndrome: A Surgical Emergency? A Case of Massive Retroperitoneal Hemorrhage.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7086195","offsetInEndSection":50,"text":"[Molecular defects in the Ehlers-Danlos syndrome.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6259441","offsetInEndSection":246,"text":"[Inheritance of an RNA splicing mutation (G+ 1 IVS20) in the type III procollagen gene (COL3A1) in a family having aortic aneurysms and easy bruisability: phenotypic overlap between familial arterial aneurysms and Ehlers-Danlos syndrome type IV.]","beginSection":"title"}],"id":"54e22b62ae9738404b000011","body":"Which genes are associated with Ehlers-Danlos syndrome type I\/II","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23237251","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23814607","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25264655","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26162926","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25595928","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22538694","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23155537","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25000345","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24117632","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26659236"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23237251","offsetInEndSection":120,"text":"[LINX(™) Reflux Management System: magnetic sphincter augmentation in the treatment of gastroesophageal reflux disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26162926","offsetInEndSection":137,"text":"[Gastroesophageal Reflux Management with the LINX® System for Gastroesophageal Reflux Disease Following Laparoscopic Sleeve Gastrectomy.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26659236","offsetInEndSection":110,"text":"[Revaluation of the efficacy of magnetic sphincter augmentation for treating gastroesophageal reflux disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23155537","offsetInEndSection":81,"text":"[[Treatment of gastroesophageal reflux disease: comments from thoracic surgeon].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22538694","offsetInEndSection":125,"text":"[LINX®, a novel treatment for patients with refractory asthma complicated by gastroesophageal reflux disease: a case report.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23814607","offsetInEndSection":144,"text":"[LINX(®) Reflux Management System in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25264655","offsetInEndSection":140,"text":"[Magnetic sphincter augmentation with the LINX device for gastroesophageal reflux disease after U.S. Food and Drug Administration approval.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25000345","offsetInEndSection":66,"text":"[Nonmedical therapeutic strategies for nonerosive reflux disease.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25595928","offsetInEndSection":89,"text":"[Optimizing Patient Selection and Outcomes for Surgical Treatment of GERD and Achalasia.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24117632","offsetInEndSection":79,"text":"[Outcomes of esophageal surgery, especially of the lower esophageal sphincter.]","beginSection":"title"}],"id":"54e22ee4ae9738404b000013","body":"Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11076767","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15094122","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7515725","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3320045","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11473126","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12666201","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10388818","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21145887","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22053084","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15094110"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11076767","offsetInEndSection":98,"text":"[Papilin in development; a pericellular protein with a homology to the ADAMTS metalloproteinases.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12666201","offsetInEndSection":118,"text":"[Alternative splicing of papilin and the diversity of Drosophila extracellular matrix during embryonic morphogenesis.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15094110","offsetInEndSection":47,"text":"[The thrombospondin type 1 repeat superfamily.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3320045","offsetInEndSection":88,"text":"[Papilin: a Drosophila proteoglycan-like sulfated glycoprotein from basement membranes.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15094122","offsetInEndSection":111,"text":"[Papilin, a novel component of basement membranes, in relation to ADAMTS metalloproteases and ECM development.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11473126","offsetInEndSection":118,"text":"[The transcription factor HLH-2\/E\/Daughterless regulates anchor cell invasion across basement membrane in C. elegans.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10388818","offsetInEndSection":145,"text":"[C. elegans mig-6 encodes papilin isoforms that affect distinct aspects of DTC migration, and interacts genetically with mig-17 and collagen IV.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7515725","offsetInEndSection":147,"text":"[Differentiation, extracellular matrix synthesis, and integrin assembly by Drosophila embryo cells cultured on vitronectin and laminin substrates.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21145887","offsetInEndSection":157,"text":"[Age-dependent transcriptome and proteome following transection of neonatal spinal cord of Monodelphis domestica (South American grey short-tailed opossum).]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22053084","offsetInEndSection":64,"text":"[GASP\/WFIKKN proteins: evolutionary aspects of their functions.]","beginSection":"title"}],"id":"54e25eaaae9738404b000017","body":"Is the protein Papilin secreted","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2168288","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2912871","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9720507","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3552910","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8308469","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2316306","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/271968","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17585539","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9381910","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12446227"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/271968","offsetInEndSection":160,"text":"[A functional cyclic AMP response element plays a crucial role in neuroendocrine cell type-specific expression of the secretory granule protein chromogranin A.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12446227","offsetInEndSection":54,"text":"[[Chromogranin A: a marker of neuroendocrine tumors].]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2168288","offsetInEndSection":144,"text":"[A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2316306","offsetInEndSection":105,"text":"[A polyclonal antiserum against chromogranin A and B--a new sensitive marker for neuroendocrine tumours.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8308469","offsetInEndSection":171,"text":"[Fragments of chromogranin A are present in the urine of patients with carcinoid tumours: development of a specific radioimmunoassay for chromogranin A and its fragments.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17585539","offsetInEndSection":165,"text":"[Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9381910","offsetInEndSection":172,"text":"[Immunohistochemical distribution of rabbit polyclonal antiurinary protein 1 antibody in the female (Skene's gland) and male prostate: new marker for neuroendocrine cells?]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9720507","offsetInEndSection":86,"text":"[Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3552910","offsetInEndSection":73,"text":"[Detection of chromogranin in argyrophil cells of endometrial carcinoma.]","beginSection":"title"},{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2912871","offsetInEndSection":109,"text":"[Paragangliomas: assessment of prognosis by histologic, immunohistochemical, and ultrastructural techniques.]","beginSection":"title"}],"id":"54e262daae9738404b000018","body":"Which cell type has the protein Chromogranin A as marker","type":"factoid"}]}